{
  "schema_version": "0.1.0",
  "case_id": "HR-BX003",
  "record_classification": {
    "synthetic": true,
    "banner": "SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD",
    "real_historical_name": true,
    "public_release_status": "draft"
  },
  "identity": {
    "person_id": "BX003",
    "display_name": "Sugar Ray Robinson",
    "aliases": [
      "Walker Smith Jr."
    ],
    "sex": "male",
    "era": "Mid-Late 20th Century",
    "nationality": "American",
    "historical_dates": {
      "birth": {
        "preferred": {
          "iso": "1921-05-03",
          "display": "May 3, 1921",
          "precision": "day",
          "calendar": "gregorian"
        },
        "alternatives": [
          {
            "date": {
              "iso": "1921",
              "display": "1921",
              "precision": "year",
              "calendar": "gregorian"
            },
            "source_ids": [
              "SRC-0006"
            ],
            "resolution_status": "preferred",
            "note": "Roster year agrees. The birthplace is disputed (Ailey, Georgia, by the Michigan Sports Hall of Fame; Detroit by UPI); the date is not."
          }
        ]
      },
      "death": {
        "preferred": {
          "iso": "1989-04-12",
          "display": "April 12, 1989",
          "precision": "day",
          "calendar": "gregorian"
        },
        "alternatives": [
          {
            "date": {
              "iso": "1989",
              "display": "1989",
              "precision": "year",
              "calendar": "gregorian"
            },
            "source_ids": [
              "SRC-0006"
            ],
            "resolution_status": "preferred",
            "note": "Roster year agrees with the cited sources."
          }
        ]
      }
    },
    "synthetic_identity": {
      "mrn": "HR-BX003-SYN",
      "ssn": "000-03-9318",
      "date_of_birth": "1963-05-03",
      "name_policy": "real_historical_name",
      "fictional_facility": "St. Posthumous Health Center",
      "fictional_primary_clinician": "Langston Pryce-Okonjo, MD",
      "fictional_consultant": {
        "name": "Mireille Haddad-Kowalski, MD",
        "specialty": "Cognitive Neurology"
      }
    }
  },
  "historical_timeline": [
    {
      "event_id": "EVT-0001",
      "date": {
        "iso": "1921-05-03",
        "display": "May 3, 1921",
        "precision": "day",
        "calendar": "gregorian"
      },
      "summary": "Born Walker Smith Jr. (Ailey, Georgia, or Detroit, by different sources).",
      "claim_ids": [
        "CLM-0001"
      ]
    },
    {
      "event_id": "EVT-0002",
      "date": {
        "iso": "1939",
        "display": "1939",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "Wins the Golden Gloves featherweight title after moving to Harlem.",
      "claim_ids": [
        "CLM-0002"
      ]
    },
    {
      "event_id": "EVT-0003",
      "date": {
        "iso": "1940",
        "display": "1940 to 1965",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "Boxes professionally for 25 years, about 200 bouts.",
      "claim_ids": [
        "CLM-0004"
      ]
    },
    {
      "event_id": "EVT-0004",
      "date": {
        "iso": "1946",
        "display": "1946",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "Wins the world welterweight title; later holds the middleweight title five times, first in 1951.",
      "claim_ids": [
        "CLM-0003"
      ]
    },
    {
      "event_id": "EVT-0005",
      "date": {
        "iso": "1969",
        "display": "1969",
        "precision": "year",
        "calendar": "gregorian"
      },
      "summary": "Founds the Sugar Ray Robinson Youth Foundation in Los Angeles.",
      "claim_ids": [
        "CLM-0005"
      ]
    },
    {
      "event_id": "EVT-0006",
      "date": {
        "iso": "1987-07",
        "display": "July 1987",
        "precision": "month",
        "calendar": "gregorian"
      },
      "summary": "Reported to have Alzheimer's disease, diabetes and hypertension.",
      "claim_ids": [
        "CLM-0006",
        "CLM-0008",
        "CLM-0009"
      ]
    },
    {
      "event_id": "EVT-0007",
      "date": {
        "iso": "1989-04-12",
        "display": "April 12, 1989",
        "precision": "day",
        "calendar": "gregorian"
      },
      "summary": "Dies at 67 at Brotman Medical Center in Culver City.",
      "claim_ids": [
        "CLM-0007"
      ]
    }
  ],
  "claims": [
    {
      "claim_id": "CLM-0001",
      "statement": "He was born Walker Smith Jr. on May 3, 1921. The Michigan Sports Hall of Fame gives his birthplace as Ailey, Georgia, with the family later moving to Detroit; the 1989 UPI obituary says he was born in Detroit.",
      "evidence_grade": "D",
      "certainty": "probable",
      "clinical_interpretation": "The date is consistent across the sources read; the birthplace is disputed. The case uses the date and records both places.",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports",
          "locator": "Born May 3, 1921, in Detroit; Robinson, born Walker Smith Jr."
        },
        {
          "source_id": "SRC-0003",
          "relationship": "supports",
          "locator": "Walker Smith Jr.; Ailey, Georgia; his family later moved to Detroit"
        },
        {
          "source_id": "SRC-0006",
          "relationship": "supports",
          "locator": "roster birth year 1921"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0002",
      "statement": "As a boy he moved with his family to Harlem in New York, and he won the Golden Gloves featherweight title in 1939.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "History only; anchors the start of his exposure to boxing.",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports",
          "locator": "moved with his family to New York's Harlem as a boy"
        },
        {
          "source_id": "SRC-0002",
          "relationship": "supports",
          "locator": "won the Golden Gloves featherweight title in 1939"
        },
        {
          "source_id": "SRC-0003",
          "relationship": "supports",
          "locator": "1939 Golden Gloves featherweight championship"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0003",
      "statement": "He held the world welterweight championship, won in 1946, and the world middleweight title five times, first in 1951.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "History only.",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports",
          "locator": "held the welterweight championship of the world once and the middleweight title five times"
        },
        {
          "source_id": "SRC-0002",
          "relationship": "supports",
          "locator": "the welterweight world title in 1946, and the middleweight title in 1951"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0004",
      "statement": "He boxed professionally from 1940 to 1965, about 200 bouts in all: the 1989 UPI obituary counts 201 fights, 109 won by knockout and 65 by decision; the 1987 UPI report gives a record of 174-19-6 and the Michigan Sports Hall of Fame 173-19-6.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "Anchors the synthetic history of repetitive head impacts over 25 years; the exact count differs by source.",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports",
          "locator": "Over his career, Robinson had 201 fights. He won 109 by knockout and 65 by decision"
        },
        {
          "source_id": "SRC-0002",
          "relationship": "supports",
          "locator": "His record was 174-19-6 from 1940 to 1965"
        },
        {
          "source_id": "SRC-0003",
          "relationship": "supports",
          "locator": "173 - 19 - 6 with 105 wins by knockout"
        },
        {
          "source_id": "SRC-0005",
          "relationship": "supports",
          "locator": "Robinson finally called time on a remarkable career"
        },
        {
          "source_id": "SRC-0006",
          "relationship": "context",
          "locator": "roster lead: welterweight/middleweight 1940-65"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0005",
      "statement": "After boxing he settled in Los Angeles, living modestly in the top story of a duplex on West Adams Boulevard, and in 1969 founded the Sugar Ray Robinson Youth Foundation for inner-city children in the Los Angeles area.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "Anchors the modern home in Los Angeles and his work with young people.",
      "source_links": [
        {
          "source_id": "SRC-0004",
          "relationship": "supports",
          "locator": "moved to Los Angeles, where they lived modestly in the top story of a duplex at the corner of West Adams Blvd; In 1969 he founded the Sugar Ray Robinson Youth Foundation for inner-city children in the Los Angeles area"
        },
        {
          "source_id": "SRC-0002",
          "relationship": "supports",
          "locator": "the Sugar Ray Robinson Youth Foundation; inner-city children of Los Angeles"
        }
      ],
      "release_status": "draft",
      "sensitive_content": false
    },
    {
      "claim_id": "CLM-0006",
      "statement": "In July 1987, at 65, he was reported (in a Sports Illustrated article summarized by UPI) to have Alzheimer's disease, diabetes and hypertension, to depend on his wife for daily care, and to be virtually incapable of speech.",
      "evidence_grade": "D",
      "certainty": "probable",
      "clinical_interpretation": "A press report of his health, not a medical record; the date of diagnosis is not given. Anchors the synthetic modern episode three years earlier, at the stage of mild dementia.",
      "source_links": [
        {
          "source_id": "SRC-0002",
          "relationship": "supports",
          "locator": "Robinson, 65, reportedly has Alzheimer's disease, diabetes, and hypertension; virtually incapable of speech"
        }
      ],
      "release_status": "draft",
      "sensitive_content": true
    },
    {
      "claim_id": "CLM-0007",
      "statement": "He died on April 12, 1989, at 67, after paramedics brought him to Brotman Medical Center in Culver City, California, in full arrest; his wife told reporters he had suffered from Alzheimer's disease and diabetes for years and that his blood sugar had been very high that morning.",
      "evidence_grade": "D",
      "certainty": "confirmed",
      "clinical_interpretation": "History after the modern episode, recorded in plain sentences.",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports",
          "locator": "died at a hospital Wednesday after suffering from Alzheimer's disease and diabetes. He was 67; Brotman Medical Center in Culver City; suffered from Alzheimer's and diabetes for years; His blood sugar went sky high"
        },
        {
          "source_id": "SRC-0004",
          "relationship": "supports",
          "locator": "Robinson, suffering from Alzheimer's disease and diabetes, died at age 67 on April 12, 1989, at the Brotman Medical Center in Culver City"
        },
        {
          "source_id": "SRC-0003",
          "relationship": "supports",
          "locator": "He died on April 12, 1989, at age 67"
        }
      ],
      "release_status": "draft",
      "sensitive_content": true
    },
    {
      "claim_id": "CLM-0008",
      "statement": "His Alzheimer's disease and diabetes are documented in the press reports of his last years; when either was diagnosed is not stated in the sources read.",
      "evidence_grade": "D",
      "certainty": "probable",
      "clinical_interpretation": "Anchors the synthetic diagnoses of Alzheimer's disease and diabetes in the modern episode.",
      "source_links": [
        {
          "source_id": "SRC-0001",
          "relationship": "supports",
          "locator": "suffered from Alzheimer's and diabetes for years"
        },
        {
          "source_id": "SRC-0002",
          "relationship": "supports",
          "locator": "reportedly has Alzheimer's disease, diabetes, and hypertension"
        }
      ],
      "release_status": "draft",
      "sensitive_content": true
    },
    {
      "claim_id": "CLM-0009",
      "statement": "Hypertension is documented only in the 1987 press report.",
      "evidence_grade": "D",
      "certainty": "possible",
      "clinical_interpretation": "Anchors the synthetic hypertension; a single press report.",
      "source_links": [
        {
          "source_id": "SRC-0002",
          "relationship": "supports",
          "locator": "reportedly has Alzheimer's disease, diabetes, and hypertension"
        }
      ],
      "release_status": "draft",
      "sensitive_content": true
    },
    {
      "claim_id": "CLM-0010",
      "statement": "The project roster describes his dementia as probable boxing-related dementia pugilistica; no source read records that diagnosis, chronic traumatic encephalopathy, or an autopsy finding.",
      "evidence_grade": "R",
      "certainty": "possible",
      "clinical_interpretation": "A retrospective interpretation from an unsourced roster, kept off the problem list. The modern episode weighs Alzheimer's disease against traumatic encephalopathy syndrome, a research diagnosis, synthetically.",
      "source_links": [
        {
          "source_id": "SRC-0006",
          "relationship": "supports",
          "locator": "roster: dementia pugilistica; probable boxing-related dementia"
        }
      ],
      "release_status": "draft",
      "sensitive_content": true
    }
  ],
  "sources": [
    {
      "source_id": "SRC-0001",
      "title": "Sugar Ray Robinson dead at 67. United Press International, April 12, 1989",
      "publisher": "United Press International",
      "url": "https://www.upi.com/Archives/1989/04/12/Sugar-Ray-Robinson-dead-at-67/7942608356800/",
      "source_type": "other",
      "published": "1989-04-12",
      "accessed": "2026-11-05",
      "rights_note": "Wire-service obituary; facts and short quotations used with citation."
    },
    {
      "source_id": "SRC-0002",
      "title": "Former boxing great Sugar Ray Robinson is suffering from Alzheimer's disease. United Press International, July 9, 1987",
      "publisher": "United Press International",
      "url": "https://www.upi.com/Archives/1987/07/09/Former-boxing-great-Sugar-Ray-Robinson-is-suffering-from/5962552801600/",
      "source_type": "other",
      "published": "1987-07-09",
      "accessed": "2026-11-05",
      "rights_note": "Wire-service report summarizing a Sports Illustrated article; used for his health in 1987 and career facts. Family disputes it reports are not used."
    },
    {
      "source_id": "SRC-0003",
      "title": "Sugar Ray Robinson. Inductee biography",
      "publisher": "Michigan Sports Hall of Fame",
      "url": "https://michigansportshof.org/inductee/sugar-ray-robinson/",
      "source_type": "biography",
      "published": null,
      "accessed": "2026-11-05",
      "rights_note": "Hall of fame biography; used for his birth name, Ailey birthplace, amateur title and record."
    },
    {
      "source_id": "SRC-0004",
      "title": "Evans L, comp. Sugar Ray Robinson",
      "publisher": "West Adams Heritage Association",
      "url": "https://westadamsheritage.org/read/457",
      "source_type": "other",
      "published": null,
      "accessed": "2026-11-05",
      "rights_note": "Local heritage association page; used for his Los Angeles home, the 1969 youth foundation and the place of death."
    },
    {
      "source_id": "SRC-0005",
      "title": "On this day: Sugar Ray Robinson, the most complete fighter to set foot in a ring, dies. Boxing News",
      "publisher": "Boxing News",
      "url": "https://boxingnewsonline.net/features/on-this-day-sugar-ray-robinson-the-most-complete-fighter-to-set-foot-in-a-ring-dies",
      "source_type": "other",
      "published": null,
      "accessed": "2026-11-05",
      "rights_note": "Boxing magazine feature; used only for the end of his career."
    },
    {
      "source_id": "SRC-0006",
      "title": "HISTMED Master Roster v3",
      "publisher": "The Human Record project",
      "url": "https://humanrecord.example.org/internal/HISTMED_Master_Roster_v3.xlsx",
      "source_type": "other",
      "published": "2026-11-01",
      "accessed": "2026-11-05",
      "rights_note": "Internal source locator; inherited claims remain provisional until corroborated."
    }
  ],
  "synthetic_episode": {
    "calendar_frame": "modern_shifted",
    "index_date": "2026-07-07",
    "index_age": 63,
    "date_shift_policy": "HR-DATE-SHIFT-1",
    "teaching_objective": "Mild dementia due to early-onset Alzheimer's disease in a 63-year-old retired boxer with type 2 diabetes and hypertension, seen in Los Angeles with his care partner. The episode follows the 2024 Alzheimer's Association DETeCD-ADRD guideline: a structured history from him and an informant, the MoCA, MMSE and CDR, function, reversible causes (B12, TSH, depression, anticholinergic medicines, sleep apnea and hearing), brain MRI, and amyloid PET to confirm the cause; how Alzheimer's disease differs from traumatic encephalopathy syndrome, a research diagnosis for people with long exposure to repetitive head impacts; why he is not a candidate for lecanemab or donanemab under the appropriate use recommendations (more than four cerebral microbleeds), and why APOE genotyping was not needed for that decision; donepezil, its pulse and stomach side effects, and a dose step back; deintensifying diabetes treatment under the ADA Standards for older adults (stopping the sulfonylurea; a goal under 8.0%) with sick-day rules for metformin; blood pressure; driving and firearm safety; hearing aids; caregiver support, respite and the Medicare GUIDE model he may join once on Medicare; and advance care planning while he can take part.",
    "visit_schedule": [
      {
        "encounter_id": "ENC-001",
        "date": "2026-07-07",
        "purpose": "Establishing care for memory loss and getting lost, with his care partner: cognitive testing, reversible causes, medicines, diabetes and blood pressure, driving and firearm safety"
      },
      {
        "encounter_id": "ENC-002",
        "date": "2026-07-21",
        "purpose": "Two-week review, seen the same day by cognitive neurology: brain MRI, hearing test, staging, Alzheimer's disease against traumatic encephalopathy syndrome, and anti-amyloid eligibility"
      },
      {
        "encounter_id": "ENC-003",
        "date": "2026-08-18",
        "purpose": "Six-week review: amyloid PET result, the diagnosis and the plan, with diabetes, driving, firearm and caregiver support"
      },
      {
        "encounter_id": "ENC-006",
        "date": "2026-09-08",
        "purpose": "Periodic adult preventive visit"
      },
      {
        "encounter_id": "ENC-004",
        "date": "2026-09-22",
        "purpose": "Eleven-week review: donepezil dose, diabetes, hearing aids and day program"
      },
      {
        "encounter_id": "ENC-007",
        "date": "2026-10-01",
        "purpose": "Same-day sick visit for nausea and dizziness on donepezil"
      },
      {
        "encounter_id": "ENC-005",
        "date": "2026-10-27",
        "purpose": "Sixteen-week review: medicines, kidneys, mood, caregiver strain and the plan"
      }
    ]
  },
  "clinical": {
    "problems": [
      {
        "id": "PRB-001",
        "display": "Memory loss over about two years, worse in the past six months, with repeated questions, missed appointments and bills, and getting lost twice while driving in familiar streets, reported by him and his care partner; cause to be found",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "R41.3",
            "display": "Other amnesia",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008",
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic presenting problem anchored to his documented Alzheimer's disease; resolved into the diagnosis at the third visit. Not a claim about his real symptoms at that age.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        },
        "clinical_status": "resolved",
        "verification_status": "confirmed",
        "problem_placement": "active",
        "abatement_date": "2026-08-18"
      },
      {
        "id": "PRB-002",
        "display": "Alzheimer's disease with early onset, confirmed by a positive amyloid PET, with an amnestic presentation; traumatic encephalopathy syndrome, a research diagnosis, considered",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "G30.0",
            "display": "Alzheimer's disease with early onset",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008",
            "CLM-0009",
            "CLM-0004"
          ],
          "synthetic_reason": "Synthetic modern diagnosis by current criteria at the third visit; not a retrospective diagnosis of the historical person beyond the documented Alzheimer's disease.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "both_with_link",
        "recorded_date": "2026-08-18"
      },
      {
        "id": "PRB-003",
        "display": "Mild dementia due to Alzheimer's disease (CDR 1, MMSE 22, MoCA 18), without behavioral or psychological symptoms",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "F02.A0",
            "display": "Dementia in other diseases classified elsewhere, mild, without behavioral disturbance, psychotic disturbance, mood disturbance, and anxiety",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008",
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic stage at diagnosis.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "active",
        "recorded_date": "2026-08-18"
      },
      {
        "id": "PRB-004",
        "display": "Type 2 diabetes for about ten years on metformin and glipizide; hemoglobin A1c 6.4%, below his goal, with hypoglycemia risk from the sulfonylurea",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "E11.9",
            "display": "Type 2 diabetes mellitus without complications",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008"
          ],
          "synthetic_reason": "Synthetic modern diabetes anchored to his documented diabetes.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "both_with_link"
      },
      {
        "id": "PRB-005",
        "display": "Hypertension, controlled on lisinopril",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "I10",
            "display": "Essential (primary) hypertension",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic modern hypertension anchored to the single press report.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "active"
      },
      {
        "id": "PRB-006",
        "display": "Bilateral sensorineural hearing loss, mild to moderate, high frequencies, on audiometry",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "H90.3",
            "display": "Sensorineural hearing loss, bilateral",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic finding checked as a modifiable contributor to cognitive difficulty.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        },
        "clinical_status": "active",
        "verification_status": "confirmed",
        "problem_placement": "active",
        "recorded_date": "2026-07-21"
      },
      {
        "id": "PRB-007",
        "display": "Nausea, loose stools, dizziness on standing and a slow pulse (56) nine days after donepezil was raised to 10 mg, with mild dehydration (creatinine 1.2 mg/dL); resolved after returning to 5 mg in the morning and two days of sick-day rules",
        "status": "draft",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/icd-10-cm",
            "code": "R11.0",
            "display": "Nausea",
            "version": "FY2026",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic adverse effect of a cholinesterase inhibitor; not a historical claim.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        },
        "clinical_status": "resolved",
        "verification_status": "confirmed",
        "problem_placement": "active",
        "recorded_date": "2026-10-01"
      }
    ],
    "medications": [
      {
        "id": "MED-001",
        "display": "Metformin 1,000 mg oral tablet, one tablet twice daily with meals",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "861004",
            "display": "metformin hydrochloride 1000 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 12,
          "period_unit": "h",
          "text": "One tablet twice daily with meals"
        },
        "start_date": "2024-03-01",
        "indication_problem_ids": [
          "PRB-004"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008"
          ],
          "synthetic_reason": "Synthetic long-standing diabetes medicine.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "MED-002",
        "display": "Glipizide 5 mg oral tablet, one tablet before breakfast",
        "status": "completed",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "310490",
            "display": "glipizide 5 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "One tablet before breakfast"
        },
        "start_date": "2025-01-15",
        "end_date": "2026-08-18",
        "indication_problem_ids": [
          "PRB-004"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008"
          ],
          "synthetic_reason": "Synthetic sulfonylurea; stopped at the diagnosis visit under the ADA advice to deintensify in older adults with cognitive impairment.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "MED-003",
        "display": "Lisinopril 20 mg oral tablet, one tablet daily",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "314077",
            "display": "lisinopril 20 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "One tablet daily"
        },
        "start_date": "2023-06-01",
        "indication_problem_ids": [
          "PRB-005"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic long-standing blood pressure medicine.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "MED-004",
        "display": "Atorvastatin 20 mg oral tablet, one tablet daily",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "617310",
            "display": "atorvastatin 20 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "One tablet daily"
        },
        "start_date": "2024-03-01",
        "indication_problem_ids": [
          "PRB-004"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic moderate-intensity statin for diabetes at 40 to 75.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "MED-005",
        "display": "Diphenhydramine 25 mg oral capsule, one at bedtime for sleep, bought over the counter",
        "status": "stopped",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "1049909",
            "display": "diphenhydramine hydrochloride 25 MG Oral Capsule",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "One capsule at bedtime"
        },
        "start_date": "2025-10-01",
        "end_date": "2026-07-07",
        "indication_problem_ids": [
          "PRB-001"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic over-the-counter sleep aid, a strongly anticholinergic drug on the Beers list; stopped at intake.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "MED-006",
        "display": "Donepezil 5 mg oral tablet, one tablet at bedtime",
        "status": "completed",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "997229",
            "display": "donepezil hydrochloride 5 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "One tablet at bedtime"
        },
        "start_date": "2026-08-18",
        "end_date": "2026-09-22",
        "indication_problem_ids": [
          "PRB-002"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008",
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic cholinesterase inhibitor started at the diagnosis visit after a normal ECG; raised at eleven weeks.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "MED-007",
        "display": "Donepezil 10 mg oral tablet, one tablet at bedtime",
        "status": "stopped",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "997223",
            "display": "donepezil hydrochloride 10 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "One tablet at bedtime"
        },
        "start_date": "2026-09-22",
        "indication_problem_ids": [
          "PRB-002"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008",
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic dose increase after five weeks at 5 mg; reduced at the sick visit for side effects.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        },
        "end_date": "2026-10-01"
      },
      {
        "id": "MED-008",
        "display": "Donepezil 5 mg oral tablet, one tablet each morning with breakfast",
        "status": "active",
        "coding": [
          {
            "system": "http://www.nlm.nih.gov/research/umls/rxnorm",
            "code": "997229",
            "display": "donepezil hydrochloride 5 MG Oral Tablet",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "dose": {
          "value": 1,
          "unit": "1"
        },
        "route": "oral",
        "frequency": {
          "period": 1,
          "period_unit": "d",
          "text": "One tablet each morning with breakfast"
        },
        "start_date": "2026-10-01",
        "indication_problem_ids": [
          "PRB-002"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic return to the tolerated dose after side effects on 10 mg.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      }
    ],
    "allergies": [
      {
        "id": "ALG-001",
        "display": "No known allergy",
        "status": "active",
        "assertion": "no_known_allergy",
        "substance": {
          "system": "http://snomed.info/sct",
          "code": "716186003",
          "display": "No known allergy"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic allergy assertion for EHR completeness; not a historical assertion.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      }
    ],
    "observations": [
      {
        "id": "OBS-WBC-V1",
        "display": "Leukocytes [#/volume] in Blood by Automated count",
        "label": "White blood cells",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-07",
        "value": 6.4,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 4.0,
          "high": 11.0
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "6690-2",
            "display": "Leukocytes [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic blood count in the first-tier laboratory work-up of cognitive impairment; normal.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-HGB-V1",
        "display": "Hemoglobin [Mass/volume] in Blood",
        "label": "Hemoglobin",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-07",
        "value": 14.1,
        "unit": "g/dL",
        "reference_range": {
          "low": 13.5,
          "high": 17.5
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "718-7",
            "display": "Hemoglobin [Mass/volume] in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic blood count in the first-tier laboratory work-up of cognitive impairment; normal.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-PLT-V1",
        "display": "Platelets [#/volume] in Blood by Automated count",
        "label": "Platelets",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-07",
        "value": 231,
        "unit": "10*3/uL",
        "reference_range": {
          "low": 150,
          "high": 400
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "777-3",
            "display": "Platelets [#/volume] in Blood by Automated count",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic blood count in the first-tier laboratory work-up of cognitive impairment; normal.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-NA-V1",
        "display": "Sodium [Moles/volume] in Serum or Plasma",
        "label": "Sodium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-07",
        "value": 140,
        "unit": "mmol/L",
        "reference_range": {
          "low": 135,
          "high": 145
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2951-2",
            "display": "Sodium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008"
          ],
          "synthetic_reason": "Synthetic metabolic panel on lisinopril and metformin; kidney function normal; non-fasting glucose.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-K-V1",
        "display": "Potassium [Moles/volume] in Serum or Plasma",
        "label": "Potassium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-07",
        "value": 4.4,
        "unit": "mmol/L",
        "reference_range": {
          "low": 3.5,
          "high": 5.1
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2823-3",
            "display": "Potassium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008"
          ],
          "synthetic_reason": "Synthetic metabolic panel on lisinopril and metformin; kidney function normal; non-fasting glucose.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-CR-V1",
        "display": "Creatinine [Mass/volume] in Serum or Plasma",
        "label": "Creatinine",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-07",
        "value": 1.0,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.74,
          "high": 1.35
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2160-0",
            "display": "Creatinine [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008"
          ],
          "synthetic_reason": "Synthetic metabolic panel on lisinopril and metformin; kidney function normal; non-fasting glucose.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-EGFR-V1",
        "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
        "label": "eGFR (CKD-EPI 2021)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-07",
        "value": 85,
        "unit": "mL/min/{1.73_m2}",
        "reference_range": {
          "low": 60
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "98979-8",
            "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008"
          ],
          "synthetic_reason": "Synthetic metabolic panel on lisinopril and metformin; kidney function normal; non-fasting glucose.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-GLU-V1",
        "display": "Glucose [Mass/volume] in Serum or Plasma",
        "label": "Glucose",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-07",
        "value": 126,
        "unit": "mg/dL",
        "reference_range": {
          "low": 70,
          "high": 140
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2345-7",
            "display": "Glucose [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008"
          ],
          "synthetic_reason": "Synthetic metabolic panel on lisinopril and metformin; kidney function normal; non-fasting glucose.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-A1C-V1",
        "display": "Hemoglobin A1c/Hemoglobin.total in Blood",
        "label": "Hemoglobin A1c",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-07",
        "value": 6.4,
        "unit": "%",
        "reference_range": {
          "high": 5.6
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "4548-4",
            "display": "Hemoglobin A1c/Hemoglobin.total in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008"
          ],
          "synthetic_reason": "Synthetic hemoglobin A1c on metformin and glipizide: below the goal of under 8.0% for an older adult with cognitive impairment, so the sulfonylurea adds hypoglycemia risk without benefit.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-B12-V1",
        "display": "Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma",
        "label": "Vitamin B12",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-07",
        "value": 352,
        "unit": "pg/mL",
        "reference_range": {
          "low": 232,
          "high": 1245
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2132-9",
            "display": "Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic vitamin B12, a reversible cause checked in every work-up and more important on long-term metformin; normal.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-TSH-V1",
        "display": "Thyrotropin [Units/volume] in Serum or Plasma",
        "label": "TSH",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-07",
        "value": 1.9,
        "unit": "m[IU]/L",
        "reference_range": {
          "low": 0.45,
          "high": 4.5
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "3016-3",
            "display": "Thyrotropin [Units/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic TSH; normal.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-UACR-V1",
        "display": "Albumin/Creatinine [Mass Ratio] in Urine",
        "label": "Urine albumin-to-creatinine ratio",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-07-07",
        "value": 14,
        "unit": "mg/g",
        "reference_range": {
          "high": 29
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "9318-7",
            "display": "Albumin/Creatinine [Mass Ratio] in Urine",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008"
          ],
          "synthetic_reason": "Synthetic yearly urine albumin-to-creatinine ratio in diabetes; normal.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-MOCA-V1",
        "display": "Total score [MoCA]",
        "label": "MoCA",
        "status": "final",
        "effective_date": "2026-07-07",
        "value": 18,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "72172-0",
            "display": "Total score [MoCA]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008",
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic MoCA (one point added for 12 years or fewer of schooling is included): below 26, with losses in delayed recall, orientation and the trail and clock tasks. Not a claim about his real cognition.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ9-V1",
        "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
        "label": "PHQ-9",
        "status": "final",
        "effective_date": "2026-07-07",
        "value": 4,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "44261-6",
            "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic PHQ-9 to look for depression as a cause of memory loss: minimal; item 9 scored 0.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-MMSE-V2",
        "display": "Mini-Mental State Examination [MMSE]",
        "label": "MMSE",
        "status": "final",
        "effective_date": "2026-07-21",
        "value": 22,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "72107-6",
            "display": "Mini-Mental State Examination [MMSE]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008",
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic MMSE given by the cognitive neurologist: within the 20 to 30 range used in the anti-amyloid appropriate use recommendations.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-CDR-V2",
        "display": "Clinical Dementia Rating scale [CDR]",
        "label": "CDR (global)",
        "status": "final",
        "effective_date": "2026-07-21",
        "value": 1,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "72088-8",
            "display": "Clinical Dementia Rating scale [CDR]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008",
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic global Clinical Dementia Rating of 1 (mild dementia; sum of boxes 5.5, narrative), from interviews with him and his care partner.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-A1C-V4",
        "display": "Hemoglobin A1c/Hemoglobin.total in Blood",
        "label": "Hemoglobin A1c",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-09-22",
        "value": 6.9,
        "unit": "%",
        "reference_range": {
          "high": 5.6
        },
        "interpretation": "H",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "4548-4",
            "display": "Hemoglobin A1c/Hemoglobin.total in Blood",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008"
          ],
          "synthetic_reason": "Synthetic hemoglobin A1c five weeks after glipizide was stopped: still within his goal of under 8.0%.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-NA-V7",
        "display": "Sodium [Moles/volume] in Serum or Plasma",
        "label": "Sodium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-01",
        "value": 138,
        "unit": "mmol/L",
        "reference_range": {
          "low": 135,
          "high": 145
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2951-2",
            "display": "Sodium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel after five days of nausea and loose stools on donepezil 10 mg: creatinine up from 1.0 with mild dehydration; glucose safe.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-K-V7",
        "display": "Potassium [Moles/volume] in Serum or Plasma",
        "label": "Potassium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-01",
        "value": 4.6,
        "unit": "mmol/L",
        "reference_range": {
          "low": 3.5,
          "high": 5.1
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2823-3",
            "display": "Potassium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel after five days of nausea and loose stools on donepezil 10 mg: creatinine up from 1.0 with mild dehydration; glucose safe.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-CR-V7",
        "display": "Creatinine [Mass/volume] in Serum or Plasma",
        "label": "Creatinine",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-01",
        "value": 1.2,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.74,
          "high": 1.35
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2160-0",
            "display": "Creatinine [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel after five days of nausea and loose stools on donepezil 10 mg: creatinine up from 1.0 with mild dehydration; glucose safe.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-EGFR-V7",
        "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
        "label": "eGFR (CKD-EPI 2021)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-01",
        "value": 68,
        "unit": "mL/min/{1.73_m2}",
        "reference_range": {
          "low": 60
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "98979-8",
            "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel after five days of nausea and loose stools on donepezil 10 mg: creatinine up from 1.0 with mild dehydration; glucose safe.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-GLU-V7",
        "display": "Glucose [Mass/volume] in Serum or Plasma",
        "label": "Glucose",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-01",
        "value": 112,
        "unit": "mg/dL",
        "reference_range": {
          "low": 70,
          "high": 140
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2345-7",
            "display": "Glucose [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic metabolic panel after five days of nausea and loose stools on donepezil 10 mg: creatinine up from 1.0 with mild dehydration; glucose safe.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-K-V5",
        "display": "Potassium [Moles/volume] in Serum or Plasma",
        "label": "Potassium",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-27",
        "value": 4.4,
        "unit": "mmol/L",
        "reference_range": {
          "low": 3.5,
          "high": 5.1
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2823-3",
            "display": "Potassium [Moles/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic recheck four weeks after the dehydration at the sick visit: back to baseline on lisinopril and metformin.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-CR-V5",
        "display": "Creatinine [Mass/volume] in Serum or Plasma",
        "label": "Creatinine",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-27",
        "value": 1.0,
        "unit": "mg/dL",
        "reference_range": {
          "low": 0.74,
          "high": 1.35
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2160-0",
            "display": "Creatinine [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic recheck four weeks after the dehydration at the sick visit: back to baseline on lisinopril and metformin.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-EGFR-V5",
        "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
        "label": "eGFR (CKD-EPI 2021)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-10-27",
        "value": 85,
        "unit": "mL/min/{1.73_m2}",
        "reference_range": {
          "low": 60
        },
        "interpretation": "N",
        "panel": {
          "code": "51990-0",
          "display": "Basic metabolic panel - Blood"
        },
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "98979-8",
            "display": "Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic recheck four weeks after the dehydration at the sick visit: back to baseline on lisinopril and metformin.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ9-V5",
        "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
        "label": "PHQ-9",
        "status": "final",
        "effective_date": "2026-10-27",
        "value": 3,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "44261-6",
            "display": "Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic PHQ-9 after the diagnosis, to look for depression: minimal; item 9 scored 0.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-CHOL-V6",
        "display": "Cholesterol [Mass/volume] in Serum or Plasma",
        "label": "Total cholesterol",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-09-08",
        "value": 154,
        "unit": "mg/dL",
        "reference_range": {
          "high": 199
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2093-3",
            "display": "Cholesterol [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic yearly lipid panel on atorvastatin 20 mg in diabetes.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-HDL-V6",
        "display": "Cholesterol in HDL [Mass/volume] in Serum or Plasma",
        "label": "HDL cholesterol",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-09-08",
        "value": 49,
        "unit": "mg/dL",
        "reference_range": {
          "low": 40
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2085-9",
            "display": "Cholesterol in HDL [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic yearly lipid panel on atorvastatin 20 mg in diabetes.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-LDL-V6",
        "display": "Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation",
        "label": "LDL cholesterol (calculated)",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-09-08",
        "value": 79,
        "unit": "mg/dL",
        "reference_range": {
          "high": 99
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "13457-7",
            "display": "Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic yearly lipid panel on atorvastatin 20 mg in diabetes.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-TG-V6",
        "display": "Triglyceride [Mass/volume] in Serum or Plasma",
        "label": "Triglycerides",
        "status": "final",
        "category": "laboratory",
        "effective_date": "2026-09-08",
        "value": 128,
        "unit": "mg/dL",
        "reference_range": {
          "high": 149
        },
        "interpretation": "N",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "2571-8",
            "display": "Triglyceride [Mass/volume] in Serum or Plasma",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic yearly lipid panel on atorvastatin 20 mg in diabetes.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "OBS-PHQ2-V6",
        "display": "Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]",
        "label": "PHQ-2",
        "status": "final",
        "effective_date": "2026-09-08",
        "value": 0,
        "unit": "{score}",
        "coding": [
          {
            "system": "http://loinc.org",
            "code": "55758-7",
            "display": "Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]",
            "version": "2.81",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic depression screen at the preventive visit; negative.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      }
    ],
    "procedures": [
      {
        "id": "PROC-001",
        "display": "MRI of the brain without contrast, with susceptibility-weighted imaging: moderate atrophy of both hippocampi, left more than right (medial temporal atrophy score 2 on each side), mild generalized atrophy, a few small white matter hyperintensities (Fazekas 1), six microbleeds at the gray-white junction of both frontal lobes and the right temporal lobe in a pattern seen after traumatic brain injury, no cortical superficial siderosis, no infarct, mass or hydrocephalus, and a cavum septi pellucidi, a finding common in boxers",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "816077007",
            "display": "MRI of brain",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "period": {
          "start": "2026-07-21",
          "end": "2026-07-21"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008",
            "CLM-0009",
            "CLM-0004"
          ],
          "synthetic_reason": "Synthetic structural MRI in the dementia work-up.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "PROC-002",
        "display": "Pure tone audiometry: mild to moderate bilateral high-frequency sensorineural hearing loss, symmetric; speech understanding good in quiet, reduced in noise",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "252577008",
            "display": "Pure tone audiometry",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "period": {
          "start": "2026-07-21",
          "end": "2026-07-21"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic hearing test, since hearing loss is a modifiable contributor to cognitive difficulty.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "PROC-003",
        "display": "Amyloid PET with florbetapir: positive, with widespread cortical tracer uptake (about 90 Centiloids), confirming Alzheimer's disease pathology",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "715173001",
            "display": "Positron emission tomography with computed tomography of brain using florbetapir (18-F)",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "period": {
          "start": "2026-08-04",
          "end": "2026-08-04"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008",
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic amyloid PET ordered at the consultation to confirm the cause of his dementia.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "PROC-004",
        "display": "Twelve-lead ECG before donepezil: sinus rhythm at 70 per minute, PR interval 172 ms, QTc 414 ms, no conduction block",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "29303009",
            "display": "Electrocardiographic procedure",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "period": {
          "start": "2026-08-18",
          "end": "2026-08-18"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic baseline ECG before a cholinesterase inhibitor.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "PROC-007",
        "display": "Fitting of hearing aids for both ears by the audiologist, with teaching for him and his care partner",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "43362002",
            "display": "Fitting of hearing aid",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "period": {
          "start": "2026-09-01",
          "end": "2026-09-01"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic hearing aid fitting two weeks after the diagnosis visit.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "PROC-005",
        "display": "Advance care planning conversation, about 30 minutes, with him and his care partner; his capacity to name a health care agent and state his values was assessed and present",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "713603004",
            "display": "Advance care planning",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "period": {
          "start": "2026-09-08",
          "end": "2026-09-08"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic voluntary advance care planning while he can take part fully.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "PROC-006",
        "display": "Twelve-lead ECG: sinus bradycardia at 56 per minute, PR interval 180 ms, QTc 420 ms, no heart block",
        "status": "completed",
        "coding": [
          {
            "system": "http://snomed.info/sct",
            "code": "29303009",
            "display": "Electrocardiographic procedure",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "period": {
          "start": "2026-10-01",
          "end": "2026-10-01"
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic ECG for a slow pulse on donepezil.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      }
    ],
    "immunizations": [
      {
        "id": "IMM-001",
        "display": "Influenza vaccine for the coming season",
        "status": "completed",
        "date": "2026-09-08",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "140",
            "display": "Influenza, split virus, trivalent, PF",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seasonal influenza vaccination.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "IMM-002",
        "display": "Pneumococcal conjugate vaccine (PCV20), recommended for all adults aged 50 and older",
        "status": "completed",
        "date": "2026-09-08",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "216",
            "display": "Pneumococcal conjugate PCV20, polysaccharide CRM197 conjugate, adjuvant, PF",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic pneumococcal vaccination at 63.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "IMM-003",
        "display": "Recombinant zoster vaccine, first of two doses",
        "status": "completed",
        "date": "2026-09-08",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "187",
            "display": "zoster recombinant",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic first zoster dose.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "IMM-004",
        "display": "Tdap vaccine, deferred from the preventive visit at his request",
        "status": "completed",
        "date": "2026-09-22",
        "coding": [
          {
            "system": "http://hl7.org/fhir/sid/cvx",
            "code": "115",
            "display": "Tdap",
            "validation_status": "validated",
            "validated_on": "2026-11-05"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic Tdap at the eleven-week visit.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      }
    ],
    "family_history": [],
    "past_medical_history": [
      {
        "id": "PMH-001",
        "display": "About 200 professional bouts over 25 years of boxing, after an amateur career: long exposure to repetitive head impacts; no source read records a knockout count with loss of consciousness or a brain injury diagnosis",
        "historical_date": {
          "iso": "1940",
          "display": "1940 to 1965",
          "precision": "year",
          "calendar": "gregorian"
        },
        "provenance": {
          "evidence_grade": "D",
          "claim_ids": [
            "CLM-0002",
            "CLM-0004"
          ],
          "synthetic_reason": null,
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      }
    ],
    "encounters": [
      {
        "id": "ENC-001",
        "display": "Establishing care for memory loss and getting lost, with his care partner: cognitive testing, reversible causes, medicines, diabetes and blood pressure, driving and firearm safety",
        "status": "finished",
        "date": "2026-07-07",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "ENC-002",
        "display": "Two-week review, seen the same day by cognitive neurology: brain MRI, hearing test, staging, Alzheimer's disease against traumatic encephalopathy syndrome, and anti-amyloid eligibility",
        "status": "finished",
        "date": "2026-07-21",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        },
        "visit_type": "chronic_care",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "390906007",
          "display": "Follow-up encounter",
          "validation_status": "validated",
          "validated_on": "2026-11-05"
        },
        "documentation": {
          "chief_complaint": "Two-week review of memory loss, seen the same day by cognitive neurology",
          "hpi": {
            "narrative": "Sugar Ray Robinson returns two weeks after intake with his care partner and is seen the same day by Dr. Haddad-Kowalski at the memory clinic. He had a brain MRI and a hearing test this morning. His intake blood count, kidney function, B12 and TSH were normal; hemoglobin A1c was 6.4%. He has slept well since stopping the over-the-counter sleep aid. He has not driven since intake; his care partner drives. The handgun stays unloaded and locked with the key held by his care partner. He repeated one question twice during the visit and laughed about it.",
            "elements": [
              {
                "label": "MMSE",
                "value": "22"
              },
              {
                "label": "CDR",
                "value": "Global 1, sum of boxes 5.5"
              },
              {
                "label": "MRI",
                "value": "Hippocampal atrophy; six microbleeds; no superficial siderosis; cavum septi pellucidi"
              },
              {
                "label": "Audiometry",
                "value": "Mild to moderate bilateral high-frequency hearing loss"
              },
              {
                "label": "Sleep",
                "value": "Sleeping well without diphenhydramine"
              }
            ]
          },
          "ros": [
            {
              "system": "Neurological",
              "status": "positive",
              "finding": "Memory loss; no headaches, weakness, tremor, falls or change in walking"
            },
            {
              "system": "Psychiatric",
              "status": "negative",
              "finding": "No low mood, hallucinations, suspiciousness or irritability"
            },
            {
              "system": "Ears, nose, mouth, and throat",
              "status": "positive",
              "finding": "Asks people to repeat themselves in noisy rooms"
            },
            {
              "system": "Endocrine",
              "status": "negative",
              "finding": "No low glucose spells he or his care partner has noticed"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Well and cheerful; blood pressure 128/78; pulse 70; weight 76.8 kg"
            },
            {
              "system": "Neurological",
              "finding": "Cranial nerves normal; no rigidity, tremor or slowness; normal strength and reflexes; steady narrow-based gait; no dysarthria"
            },
            {
              "system": "Mental status",
              "finding": "Alert and courteous; repeats questions; mood good; no psychotic symptoms"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-001",
              "display": "Memory loss with getting lost",
              "assessment": "Dr. Haddad-Kowalski finds mild dementia (CDR 1, MMSE 22) with an amnestic pattern and hippocampal atrophy, most likely due to Alzheimer's disease; long exposure to repetitive head impacts raises traumatic encephalopathy syndrome, a research diagnosis, as a contributor; vascular change is slight. Reversible causes have been excluded or treated. The six microbleeds rule out lecanemab and donanemab under the appropriate use recommendations, so APOE genotyping is not needed for that decision. An amyloid PET will confirm or exclude Alzheimer's disease, which he wants to know",
              "plan": [
                "Amyloid PET in two weeks",
                "Results and next steps at the six-week visit, with his care partner present at his request",
                "No driving until then"
              ]
            },
            {
              "problem_id": "PRB-006",
              "display": "Bilateral sensorineural hearing loss",
              "assessment": "Mild to moderate high-frequency loss that makes conversation harder and may add to his difficulty; hearing aids can help",
              "plan": [
                "Hearing aid assessment with the audiologist"
              ]
            },
            {
              "problem_id": "PRB-004",
              "display": "Type 2 diabetes",
              "assessment": "Hemoglobin A1c 6.4% on metformin and glipizide, below his goal; the sulfonylurea will be reviewed when the diagnosis is settled",
              "plan": [
                "Home glucose readings twice a day until the next visit"
              ]
            }
          ],
          "monitoring": [
            {
              "domain": "survey",
              "measure": "Cognitive testing (MoCA, MMSE)",
              "cadence": "At diagnosis, then yearly, or sooner with change",
              "status": "completed_today",
              "detail": "MoCA 18 at intake; MMSE 22 today",
              "observation_ids": [
                "OBS-MMSE-V2"
              ],
              "guideline_ids": [
                "GL-ALZ-2024",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "survey",
              "measure": "Dementia staging (CDR) and function (ADL and IADL)",
              "cadence": "At diagnosis, then yearly",
              "status": "completed_today",
              "detail": "Global CDR 1 (sum of boxes 5.5); independent in personal care, needs help with bills, medicines and appointments (Functional Activities Questionnaire 11)",
              "observation_ids": [
                "OBS-CDR-V2"
              ],
              "guideline_ids": [
                "GL-ALZ-2024",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Reversible causes: blood count, metabolic panel, B12, TSH, depression, sleep apnea, hearing",
              "cadence": "Once at diagnosis",
              "status": "completed_today",
              "detail": "Blood count, metabolic panel, B12 352 pg/mL and TSH 1.9 at intake, normal; PHQ-9 4; diphenhydramine stopped; STOP-Bang 2 (low risk of sleep apnea); hearing loss on audiometry today",
              "guideline_ids": [
                "GL-ALZ-2024",
                "GL-CMID-2026",
                "GL-ALZ-PC-2024"
              ]
            },
            {
              "domain": "imaging",
              "measure": "Brain MRI",
              "cadence": "Once at diagnosis; repeat only with an acute change",
              "status": "completed_today",
              "detail": "Moderate hippocampal atrophy; six microbleeds; no siderosis or infarct; cavum septi pellucidi",
              "guideline_ids": [
                "GL-ALZ-2024",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "imaging",
              "measure": "Amyloid biomarker confirmation (PET or CSF)",
              "cadence": "Once, when it will change diagnosis or treatment",
              "status": "ordered",
              "detail": "Amyloid PET booked in two weeks",
              "guideline_ids": [
                "GL-ALZ-2024",
                "GL-CMID-2026",
                "GL-AUR-LEC-2023",
                "GL-AUR-DON-2025"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Anti-amyloid antibody eligibility (lecanemab, donanemab), APOE genotyping and ARIA MRI schedule",
              "cadence": "At diagnosis of MCI or mild dementia due to Alzheimer's disease",
              "status": "not_indicated",
              "detail": "Not a candidate: more than four cerebral microbleeds exclude lecanemab and donanemab under both appropriate use recommendations; APOE genotyping therefore not needed for treatment and offered only with counseling (declined); no ARIA monitoring schedule",
              "guideline_ids": [
                "GL-AUR-LEC-2023",
                "GL-AUR-DON-2025"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Medicine review for anticholinergic and sedating drugs (Beers)",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Diphenhydramine stopped at intake; no other anticholinergic or sedating drugs",
              "guideline_ids": [
                "GL-BEERS-2023"
              ]
            },
            {
              "domain": "survey",
              "measure": "Behavioral and psychological symptoms (NPI-Q items)",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "None: no agitation, apathy, low mood, anxiety, hallucinations, delusions or sleep disturbance",
              "guideline_ids": [
                "GL-ALZ-2024",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Cholinesterase inhibitor: benefit, nausea, diarrhea, dreams, pulse",
              "cadence": "Each follow-up and each dose change",
              "status": "not_indicated",
              "detail": "Not started until the cause is confirmed",
              "guideline_ids": [
                "GL-ALZ-2024",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Driving, firearm and home safety",
              "cadence": "At diagnosis and each follow-up",
              "status": "completed_today",
              "detail": "Not driving; handgun unloaded and locked with the key held by his care partner; no wandering",
              "guideline_ids": [
                "GL-AAN-DRIVING-2010",
                "GL-ALZ-2024",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Care partner support and burden (Zarit, narrative)",
              "cadence": "At diagnosis, then at least yearly",
              "status": "due",
              "detail": "At the diagnosis visit",
              "guideline_ids": [
                "GL-ALZ-2024",
                "GL-CMID-2026",
                "GL-GUIDE"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Advance care planning",
              "cadence": "At diagnosis; revisit yearly and at changes",
              "status": "due",
              "detail": "Planned at the preventive visit",
              "guideline_ids": [
                "GL-ALZ-2024",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Hemoglobin A1c, goal under 8.0% for an older adult with cognitive impairment, and hypoglycemia review",
              "cadence": "Every three months after a therapy change; every six months when stable",
              "status": "up_to_date",
              "detail": "6.4% at intake; no low readings",
              "guideline_ids": [
                "GL-ADA-OLDER-2026",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "examination",
              "measure": "Blood pressure, goal under 130/80 mmHg",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "128/78 mmHg on lisinopril",
              "guideline_ids": [
                "GL-ADA-OLDER-2026",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Potassium and creatinine on lisinopril and metformin",
              "cadence": "Yearly, and after acute illness or dehydration",
              "status": "up_to_date",
              "detail": "Potassium 4.4 mmol/L, creatinine 1.0 mg/dL at intake",
              "guideline_ids": [
                "GL-ADA-OLDER-2026",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "examination",
              "measure": "Dilated diabetic eye examination",
              "cadence": "Every one to two years without retinopathy",
              "status": "referred",
              "detail": "Requested at intake; appointment pending",
              "guideline_ids": [
                "GL-ADA-OLDER-2026",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "referral",
              "measure": "Cognitive neurology consultation",
              "cadence": "At diagnosis",
              "status": "completed_today",
              "detail": "Seen by Dr. Haddad-Kowalski today",
              "guideline_ids": [
                "GL-ALZ-2024",
                "GL-CMID-2026"
              ]
            }
          ],
          "follow_up": "Amyloid PET in two weeks. Six-week review for results, with his care partner. Hearing aid assessment. Call with any new confusion, falls or low glucose readings",
          "guideline_ids": [
            "GL-ALZ-2024",
            "GL-ALZ-PC-2024",
            "GL-CMID-2026",
            "GL-AUR-LEC-2023",
            "GL-AUR-DON-2025",
            "GL-TES-2021",
            "GL-BEERS-2023",
            "GL-AAN-DRIVING-2010"
          ]
        }
      },
      {
        "id": "ENC-003",
        "display": "Six-week review: amyloid PET result, the diagnosis and the plan, with diabetes, driving, firearm and caregiver support",
        "status": "finished",
        "date": "2026-08-18",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        },
        "visit_type": "chronic_care",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "390906007",
          "display": "Follow-up encounter",
          "validation_status": "validated",
          "validated_on": "2026-11-05"
        },
        "documentation": {
          "chief_complaint": "Six-week review: amyloid PET result and the diagnosis",
          "hpi": {
            "narrative": "Sugar Ray Robinson returns six weeks after intake with his care partner, whom he asked to be present. The amyloid PET two weeks ago was positive. He was asked first how much he wanted to know and said he wanted it straight. The diagnosis of Alzheimer's disease at the stage of mild dementia was explained with the PET, MRI and test results, in plain words and in writing. He was quiet, then asked whether boxing had caused it; that question was answered honestly. His home glucose readings ran 95 to 150 mg/dL, with one reading of 68 mg/dL before lunch on glipizide. He has not driven. His care partner finds the evenings and the repeated questions tiring.",
            "elements": [
              {
                "label": "Amyloid PET",
                "value": "Positive, widespread cortical uptake"
              },
              {
                "label": "Diagnosis",
                "value": "Mild dementia due to Alzheimer's disease, early onset"
              },
              {
                "label": "Home glucose",
                "value": "95 to 150 mg/dL; one reading of 68 mg/dL on glipizide"
              },
              {
                "label": "ECG",
                "value": "Sinus rhythm 70, normal intervals"
              },
              {
                "label": "Care partner",
                "value": "Zarit Burden Interview 18 (mild), narrative"
              }
            ]
          },
          "ros": [
            {
              "system": "Neurological",
              "status": "positive",
              "finding": "Memory loss unchanged; no falls"
            },
            {
              "system": "Psychiatric",
              "status": "negative",
              "finding": "Sad at the news but not depressed; no thoughts of self-harm"
            },
            {
              "system": "Endocrine",
              "status": "positive",
              "finding": "One low glucose reading before lunch, with sweating"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Well; blood pressure 126/78; pulse 70; weight 76.6 kg"
            },
            {
              "system": "Mental status",
              "finding": "Attentive during the disclosure; asks good questions; mood sad but reactive"
            },
            {
              "system": "Gait",
              "finding": "Steady; Timed Up and Go 9 seconds"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-002",
              "display": "Alzheimer's disease with early onset",
              "assessment": "Amyloid PET positive: the amnestic mild dementia is due to Alzheimer's disease, beginning before 65. Repetitive head impacts may have added to his difficulty, and traumatic encephalopathy syndrome remains a research diagnosis that cannot be confirmed in life; it would not change his treatment. He is not a candidate for anti-amyloid antibodies because of the microbleeds. Donepezil offered for modest benefit and accepted after a normal ECG",
              "plan": [
                "Donepezil 5 mg at bedtime; raise to 10 mg after four to six weeks if tolerated",
                "MoCA and CDR yearly, or sooner with change",
                "Exercise and social activity to continue"
              ]
            },
            {
              "problem_id": "PRB-003",
              "display": "Mild dementia due to Alzheimer's disease",
              "assessment": "CDR 1. Getting lost while driving and the CDR put him at high risk at the wheel; after discussion he agreed to stop driving. He agreed to have the handgun taken out of the home",
              "plan": [
                "No driving; transport through his care partner and paratransit",
                "Handgun removed from the home",
                "Care partner: Alzheimer's Association 24/7 Helpline, a caregiver class, and an adult day program two days a week for respite",
                "GUIDE dementia care program once he has Medicare"
              ]
            },
            {
              "problem_id": "PRB-004",
              "display": "Type 2 diabetes",
              "assessment": "A low reading of 68 mg/dL on glipizide with hemoglobin A1c 6.4%: under the ADA Standards for an older adult with cognitive impairment, the goal is under 8.0% and sulfonylureas should be stopped to avoid hypoglycemia",
              "plan": [
                "Stop glipizide",
                "Continue metformin; hold it on days he cannot eat or drink",
                "Hemoglobin A1c at about three months"
              ]
            },
            {
              "problem_id": "PRB-006",
              "display": "Bilateral sensorineural hearing loss",
              "assessment": "Hearing aids recommended by the audiologist",
              "plan": [
                "Hearing aid fitting in two weeks"
              ]
            }
          ],
          "monitoring": [
            {
              "domain": "survey",
              "measure": "Cognitive testing (MoCA, MMSE)",
              "cadence": "At diagnosis, then yearly, or sooner with change",
              "status": "up_to_date",
              "detail": "MoCA 18 and MMSE 22 at diagnosis; next in a year",
              "guideline_ids": [
                "GL-ALZ-2024",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "survey",
              "measure": "Dementia staging (CDR) and function (ADL and IADL)",
              "cadence": "At diagnosis, then yearly",
              "status": "up_to_date",
              "detail": "CDR 1 two weeks ago",
              "guideline_ids": [
                "GL-ALZ-2024",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "imaging",
              "measure": "Amyloid biomarker confirmation (PET or CSF)",
              "cadence": "Once, when it will change diagnosis or treatment",
              "status": "completed_today",
              "detail": "Amyloid PET positive (about 90 Centiloids), reviewed with him today",
              "guideline_ids": [
                "GL-ALZ-2024",
                "GL-CMID-2026",
                "GL-AUR-LEC-2023",
                "GL-AUR-DON-2025"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Anti-amyloid antibody eligibility (lecanemab, donanemab), APOE genotyping and ARIA MRI schedule",
              "cadence": "At diagnosis of MCI or mild dementia due to Alzheimer's disease",
              "status": "not_indicated",
              "detail": "Not a candidate because of six microbleeds; explained to him today",
              "guideline_ids": [
                "GL-AUR-LEC-2023",
                "GL-AUR-DON-2025"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Medicine review for anticholinergic and sedating drugs (Beers)",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "No anticholinergic or sedating drugs; glipizide stopped for hypoglycemia risk",
              "guideline_ids": [
                "GL-BEERS-2023",
                "GL-ADA-OLDER-2026",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "survey",
              "measure": "Behavioral and psychological symptoms (NPI-Q items)",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "None; sad at the news without depression",
              "guideline_ids": [
                "GL-ALZ-2024",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Cholinesterase inhibitor: benefit, nausea, diarrhea, dreams, pulse",
              "cadence": "Each follow-up and each dose change",
              "status": "completed_today",
              "detail": "Donepezil 5 mg started after a normal ECG (pulse 70)",
              "guideline_ids": [
                "GL-ALZ-2024",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Driving, firearm and home safety",
              "cadence": "At diagnosis and each follow-up",
              "status": "completed_today",
              "detail": "Agreed to stop driving; handgun to be removed from the home; stove shut-off advised",
              "guideline_ids": [
                "GL-AAN-DRIVING-2010",
                "GL-ALZ-2024",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Care partner support and burden (Zarit, narrative)",
              "cadence": "At diagnosis, then at least yearly",
              "status": "completed_today",
              "detail": "Zarit 18 (mild burden); helpline, caregiver class and adult day program arranged; GUIDE explained for when he has Medicare",
              "guideline_ids": [
                "GL-ALZ-2024",
                "GL-CMID-2026",
                "GL-GUIDE"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Advance care planning",
              "cadence": "At diagnosis; revisit yearly and at changes",
              "status": "due",
              "detail": "Booked at the preventive visit in three weeks, while he can take part fully",
              "guideline_ids": [
                "GL-ALZ-2024",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Hemoglobin A1c, goal under 8.0% for an older adult with cognitive impairment, and hypoglycemia review",
              "cadence": "Every three months after a therapy change; every six months when stable",
              "status": "up_to_date",
              "detail": "6.4% at intake; one low reading; glipizide stopped; A1c due in about three months",
              "guideline_ids": [
                "GL-ADA-OLDER-2026",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "examination",
              "measure": "Blood pressure, goal under 130/80 mmHg",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "126/78 mmHg",
              "guideline_ids": [
                "GL-ADA-OLDER-2026",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Potassium and creatinine on lisinopril and metformin",
              "cadence": "Yearly, and after acute illness or dehydration",
              "status": "up_to_date",
              "detail": "Normal at intake",
              "guideline_ids": [
                "GL-ADA-OLDER-2026",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "examination",
              "measure": "Dilated diabetic eye examination",
              "cadence": "Every one to two years without retinopathy",
              "status": "referred",
              "detail": "Still pending; he now depends on others for transport",
              "guideline_ids": [
                "GL-ADA-OLDER-2026",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Exercise and social activity",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Walks daily; the foundation gym twice a week",
              "guideline_ids": [
                "GL-ALZ-2024",
                "GL-CMID-2026"
              ]
            }
          ],
          "follow_up": "Preventive visit with advance care planning in three weeks. Hearing aid fitting in two weeks. Eleven-week review with hemoglobin A1c. Call for low glucose readings, falls, or nausea on donepezil",
          "guideline_ids": [
            "GL-ALZ-2024",
            "GL-CMID-2026",
            "GL-AUR-LEC-2023",
            "GL-AUR-DON-2025",
            "GL-TES-2021",
            "GL-ADA-OLDER-2026",
            "GL-AAN-DRIVING-2010",
            "GL-GUIDE"
          ]
        }
      },
      {
        "id": "ENC-004",
        "display": "Eleven-week review: donepezil dose, diabetes, hearing aids and day program",
        "status": "finished",
        "date": "2026-09-22",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        },
        "visit_type": "chronic_care",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "390906007",
          "display": "Follow-up encounter",
          "validation_status": "validated",
          "validated_on": "2026-11-05"
        },
        "documentation": {
          "chief_complaint": "Eleven-week review: donepezil, diabetes, hearing aids and day program",
          "hpi": {
            "narrative": "Sugar Ray Robinson returns eleven weeks after intake with his care partner, two weeks after his preventive visit. He has taken donepezil 5 mg at bedtime for five weeks without nausea, diarrhea or dizziness. Off glipizide, his home glucose readings run 120 to 170 mg/dL with no low readings. The hearing aids help most in conversation. He started the adult day program two days a week and likes the exercise group. The dilated eye examination booked after intake was missed: the clinic called the day before, but nobody at home remembered on the morning, and he no longer drives himself. He would like his Tdap today.",
            "elements": [
              {
                "label": "Donepezil",
                "value": "5 mg for five weeks; no side effects"
              },
              {
                "label": "Hemoglobin A1c",
                "value": "6.9%, from 6.4%"
              },
              {
                "label": "Home glucose",
                "value": "120 to 170 mg/dL; no lows"
              },
              {
                "label": "Hearing aids",
                "value": "Worn daily"
              },
              {
                "label": "Eye examination",
                "value": "Missed"
              }
            ]
          },
          "ros": [
            {
              "system": "Gastrointestinal",
              "status": "negative",
              "finding": "No nausea, diarrhea or weight loss"
            },
            {
              "system": "Cardiovascular",
              "status": "negative",
              "finding": "No dizziness or fainting"
            },
            {
              "system": "Neurological",
              "status": "positive",
              "finding": "Memory loss unchanged; no falls"
            },
            {
              "system": "Psychiatric",
              "status": "negative",
              "finding": "Mood good; enjoys the day program"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Well; blood pressure 128/76; pulse 64 and regular; weight 76.2 kg"
            },
            {
              "system": "Mental status",
              "finding": "Cheerful; follows conversation better with the hearing aids"
            },
            {
              "system": "Gait",
              "finding": "Steady"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-002",
              "display": "Alzheimer's disease with early onset",
              "assessment": "Donepezil 5 mg tolerated for five weeks; pulse 64",
              "plan": [
                "Donepezil 10 mg at bedtime",
                "Call for nausea, loose stools, dizziness or a pulse below 55"
              ]
            },
            {
              "problem_id": "PRB-004",
              "display": "Type 2 diabetes",
              "assessment": "Hemoglobin A1c 6.9% off glipizide, within his goal of under 8.0%, with no low readings",
              "plan": [
                "Continue metformin",
                "Hemoglobin A1c in six months",
                "Eye examination re-booked with paratransit and a same-morning reminder call to his care partner"
              ]
            }
          ],
          "monitoring": [
            {
              "domain": "survey",
              "measure": "Cognitive testing (MoCA, MMSE)",
              "cadence": "At diagnosis, then yearly, or sooner with change",
              "status": "up_to_date",
              "detail": "Next in a year",
              "guideline_ids": [
                "GL-ALZ-2024",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Medicine review for anticholinergic and sedating drugs (Beers)",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "No anticholinergic or sedating drugs",
              "guideline_ids": [
                "GL-BEERS-2023"
              ]
            },
            {
              "domain": "survey",
              "measure": "Behavioral and psychological symptoms (NPI-Q items)",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "None",
              "guideline_ids": [
                "GL-ALZ-2024",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Cholinesterase inhibitor: benefit, nausea, diarrhea, dreams, pulse",
              "cadence": "Each follow-up and each dose change",
              "status": "completed_today",
              "detail": "Five weeks on 5 mg without side effects; pulse 64; raised to 10 mg today",
              "guideline_ids": [
                "GL-ALZ-2024",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Driving, firearm and home safety",
              "cadence": "At diagnosis and each follow-up",
              "status": "completed_today",
              "detail": "Not driving; no firearm in the home; stove shut-off fitted",
              "guideline_ids": [
                "GL-AAN-DRIVING-2010",
                "GL-ALZ-2024",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Care partner support and burden (Zarit, narrative)",
              "cadence": "At diagnosis, then at least yearly",
              "status": "completed_today",
              "detail": "Adult day program two days a week; caregiver class started",
              "guideline_ids": [
                "GL-ALZ-2024",
                "GL-CMID-2026",
                "GL-GUIDE"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Advance care planning",
              "cadence": "At diagnosis; revisit yearly and at changes",
              "status": "up_to_date",
              "detail": "Completed at the preventive visit two weeks ago",
              "guideline_ids": [
                "GL-ALZ-2024",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Hemoglobin A1c, goal under 8.0% for an older adult with cognitive impairment, and hypoglycemia review",
              "cadence": "Every three months after a therapy change; every six months when stable",
              "status": "completed_today",
              "detail": "6.9%, from 6.4%, off glipizide; no low readings",
              "observation_ids": [
                "OBS-A1C-V4"
              ],
              "guideline_ids": [
                "GL-ADA-OLDER-2026",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "examination",
              "measure": "Blood pressure, goal under 130/80 mmHg",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "128/76 mmHg",
              "guideline_ids": [
                "GL-ADA-OLDER-2026",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Potassium and creatinine on lisinopril and metformin",
              "cadence": "Yearly, and after acute illness or dehydration",
              "status": "up_to_date",
              "detail": "Normal at intake",
              "guideline_ids": [
                "GL-ADA-OLDER-2026",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "examination",
              "measure": "Dilated diabetic eye examination",
              "cadence": "Every one to two years without retinopathy",
              "status": "deferred",
              "detail": "The dilated eye examination requested at intake was missed because he no longer drives and the appointment was forgotten on the morning. No harm is known: he has no visual symptoms and his diabetes is well controlled, but retinopathy cannot be excluded until he is examined. Corrective action: re-booked with paratransit, a same-morning reminder call to his care partner, and the appointment added to the day program's calendar",
              "guideline_ids": [
                "GL-ADA-OLDER-2026",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Exercise and social activity",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Day program exercise group and daily walks",
              "guideline_ids": [
                "GL-ALZ-2024",
                "GL-CMID-2026"
              ]
            }
          ],
          "follow_up": "Tdap given today. Eye examination as re-booked. Sixteen-week review in five weeks. Call for side effects of the higher donepezil dose",
          "guideline_ids": [
            "GL-ALZ-2024",
            "GL-CMID-2026",
            "GL-ADA-OLDER-2026",
            "GL-BEERS-2023",
            "GL-AAN-DRIVING-2010",
            "GL-CDC-IMZ-2026"
          ]
        }
      },
      {
        "id": "ENC-005",
        "display": "Sixteen-week review: medicines, kidneys, mood, caregiver strain and the plan",
        "status": "finished",
        "date": "2026-10-27",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic modern EHR encounter.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        },
        "visit_type": "chronic_care",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "390906007",
          "display": "Follow-up encounter",
          "validation_status": "validated",
          "validated_on": "2026-11-05"
        },
        "documentation": {
          "chief_complaint": "Sixteen-week review after the sick visit",
          "hpi": {
            "narrative": "Sugar Ray Robinson returns sixteen weeks after intake with his care partner, four weeks after the sick visit for nausea, loose stools and a slow pulse on donepezil 10 mg. Since returning to 5 mg in the morning his stomach has settled, the vivid dreams stopped, and he has not been dizzy. Metformin and lisinopril were restarted after two days. He had the dilated eye examination two weeks ago, with no retinopathy. He goes to the day program twice a week and to the foundation gym once. His care partner is sleeping better with the day program and the caregiver class.",
            "elements": [
              {
                "label": "Donepezil",
                "value": "5 mg each morning; no side effects"
              },
              {
                "label": "Creatinine",
                "value": "1.0 mg/dL, from 1.2 at the sick visit"
              },
              {
                "label": "Eye examination",
                "value": "No diabetic retinopathy"
              },
              {
                "label": "PHQ-9",
                "value": "3"
              },
              {
                "label": "Care partner",
                "value": "Zarit 16, narrative"
              }
            ]
          },
          "ros": [
            {
              "system": "Gastrointestinal",
              "status": "negative",
              "finding": "No nausea or diarrhea"
            },
            {
              "system": "Cardiovascular",
              "status": "negative",
              "finding": "No dizziness or fainting"
            },
            {
              "system": "Neurological",
              "status": "positive",
              "finding": "Memory loss unchanged; no falls"
            },
            {
              "system": "Psychiatric",
              "status": "negative",
              "finding": "Mood good; no thoughts of self-harm"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Well; blood pressure 126/76 seated and 124/74 standing; pulse 66 and regular; weight 75.8 kg"
            },
            {
              "system": "Mouth",
              "finding": "Moist mucous membranes"
            },
            {
              "system": "Mental status",
              "finding": "Cheerful and engaged; repeats a story once"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-002",
              "display": "Alzheimer's disease with early onset",
              "assessment": "Donepezil 5 mg each morning is tolerated; 10 mg was not. He and his care partner prefer to stay at 5 mg for now rather than retry 10 mg or switch to a rivastigmine patch. Memantine is not indicated at the mild stage",
              "plan": [
                "Continue donepezil 5 mg each morning",
                "MoCA and CDR in six to twelve months",
                "Revisit the dose, or a rivastigmine patch, if he declines"
              ]
            },
            {
              "problem_id": "PRB-004",
              "display": "Type 2 diabetes",
              "assessment": "Kidney function back to baseline; no retinopathy",
              "plan": [
                "Continue metformin with sick-day rules",
                "Hemoglobin A1c in five months; eye examination in one to two years"
              ]
            },
            {
              "problem_id": "PRB-003",
              "display": "Mild dementia due to Alzheimer's disease",
              "assessment": "Stable; no behavioral symptoms; safe at home with the day program; care partner strain lower",
              "plan": [
                "Continue the day program and the caregiver class",
                "GUIDE dementia care program when he has Medicare",
                "Advance care plan reviewed in six months"
              ]
            }
          ],
          "monitoring": [
            {
              "domain": "survey",
              "measure": "Cognitive testing (MoCA, MMSE)",
              "cadence": "At diagnosis, then yearly, or sooner with change",
              "status": "up_to_date",
              "detail": "Next in six to twelve months",
              "guideline_ids": [
                "GL-ALZ-2024",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Medicine review for anticholinergic and sedating drugs (Beers)",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "No anticholinergic or sedating drugs",
              "guideline_ids": [
                "GL-BEERS-2023"
              ]
            },
            {
              "domain": "survey",
              "measure": "Behavioral and psychological symptoms (NPI-Q items)",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "None",
              "guideline_ids": [
                "GL-ALZ-2024",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "medication_safety",
              "measure": "Cholinesterase inhibitor: benefit, nausea, diarrhea, dreams, pulse",
              "cadence": "Each follow-up and each dose change",
              "status": "completed_today",
              "detail": "5 mg each morning tolerated; pulse 66; 10 mg not tolerated (sick visit)",
              "guideline_ids": [
                "GL-ALZ-2024",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "survey",
              "measure": "Depression screen (PHQ-9)",
              "cadence": "At diagnosis and yearly",
              "status": "completed_today",
              "detail": "3; item 9 scored 0",
              "observation_ids": [
                "OBS-PHQ9-V5"
              ],
              "guideline_ids": [
                "GL-ALZ-2024",
                "GL-CMID-2026",
                "GL-USPSTF-DEP-2023"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Driving, firearm and home safety",
              "cadence": "At diagnosis and each follow-up",
              "status": "completed_today",
              "detail": "Not driving; no firearm in the home; no wandering",
              "guideline_ids": [
                "GL-AAN-DRIVING-2010",
                "GL-ALZ-2024",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Care partner support and burden (Zarit, narrative)",
              "cadence": "At diagnosis, then at least yearly",
              "status": "completed_today",
              "detail": "Zarit 16, from 18; day program and caregiver class",
              "guideline_ids": [
                "GL-ALZ-2024",
                "GL-CMID-2026",
                "GL-GUIDE"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Hemoglobin A1c, goal under 8.0% for an older adult with cognitive impairment, and hypoglycemia review",
              "cadence": "Every three months after a therapy change; every six months when stable",
              "status": "up_to_date",
              "detail": "6.9% five weeks ago; no low readings",
              "guideline_ids": [
                "GL-ADA-OLDER-2026",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "examination",
              "measure": "Blood pressure, goal under 130/80 mmHg",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "126/76 mmHg; no standing drop",
              "guideline_ids": [
                "GL-ADA-OLDER-2026",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "laboratory",
              "measure": "Potassium and creatinine on lisinopril and metformin",
              "cadence": "Yearly, and after acute illness or dehydration",
              "status": "completed_today",
              "detail": "Potassium 4.4 mmol/L, creatinine 1.0 mg/dL (eGFR 85), back to baseline after the dehydration",
              "observation_ids": [
                "OBS-K-V5",
                "OBS-CR-V5",
                "OBS-EGFR-V5"
              ],
              "guideline_ids": [
                "GL-ADA-OLDER-2026",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "examination",
              "measure": "Dilated diabetic eye examination",
              "cadence": "Every one to two years without retinopathy",
              "status": "completed_today",
              "detail": "Dilated examination two weeks ago: no retinopathy",
              "guideline_ids": [
                "GL-ADA-OLDER-2026",
                "GL-CMID-2026"
              ]
            },
            {
              "domain": "self_management",
              "measure": "Exercise and social activity",
              "cadence": "Every visit",
              "status": "completed_today",
              "detail": "Day program exercise, daily walks and the foundation gym",
              "guideline_ids": [
                "GL-ALZ-2024",
                "GL-CMID-2026"
              ]
            }
          ],
          "follow_up": "Second recombinant zoster dose due two to six months after the first. Review in three months. Call for side effects, falls, low glucose readings or new behavior changes",
          "guideline_ids": [
            "GL-ALZ-2024",
            "GL-CMID-2026",
            "GL-ADA-OLDER-2026",
            "GL-BEERS-2023",
            "GL-AAN-DRIVING-2010",
            "GL-GUIDE"
          ]
        }
      },
      {
        "id": "ENC-006",
        "display": "Periodic adult preventive visit",
        "status": "finished",
        "date": "2026-09-08",
        "visit_type": "preventive_adult",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "86013001",
          "display": "Periodic reevaluation and management of healthy individual",
          "validation_status": "validated",
          "validated_on": "2026-11-05"
        },
        "documentation": {
          "chief_complaint": "Periodic adult preventive visit",
          "billing_note": "CPT 99396 (periodic preventive medicine, established patient, age 40 to 64) with CPT 99497 (advance care planning), both on the same day",
          "health_risk_assessment_method": "Completed with him and his care partner at the visit, with large print and one question at a time, and reviewed by Dr. Pryce-Okonjo",
          "hpi": {
            "narrative": "Sugar Ray Robinson is a man of 63 with mild dementia due to Alzheimer's disease, type 2 diabetes and hypertension who comes with his care partner for his yearly preventive visit, three weeks after the diagnosis was explained to him. He takes donepezil 5 mg at bedtime without side effects so far, and he no longer takes glipizide; his home glucose readings run 120 to 170 mg/dL with no low readings. He has not driven since intake, and the handgun has been taken out of the home. His new hearing aids were fitted last week, and he says the television is clearer. He wants to settle who will speak for him while he can still decide it himself.",
            "elements": [
              {
                "label": "Visit",
                "value": "Periodic adult preventive visit, age 63"
              },
              {
                "label": "Memory",
                "value": "Mild dementia due to Alzheimer's disease; donepezil 5 mg"
              },
              {
                "label": "Diabetes",
                "value": "Glipizide stopped; home glucose 120 to 170 mg/dL, no lows"
              },
              {
                "label": "Mood",
                "value": "PHQ-2 0"
              },
              {
                "label": "Hearing",
                "value": "Hearing aids fitted last week"
              }
            ]
          },
          "health_risk_assessment": [
            {
              "domain": "Self-rated health",
              "finding": "Good, apart from his memory"
            },
            {
              "domain": "Psychosocial",
              "finding": "Lives with his care partner; friends from boxing; visits the foundation gym"
            },
            {
              "domain": "Alcohol",
              "finding": "A glass of wine on special occasions"
            },
            {
              "domain": "Tobacco",
              "finding": "Never smoked"
            },
            {
              "domain": "Physical activity",
              "finding": "Walks an hour and skips rope most days"
            },
            {
              "domain": "Nutrition",
              "finding": "Two large meals a day; fewer sweets since the diabetes review"
            },
            {
              "domain": "Sleep",
              "finding": "Sleeps seven hours without the over-the-counter sleep aid; light snoring, no pauses noticed by his care partner"
            },
            {
              "domain": "Safety at home",
              "finding": "No firearm in the home; stove left on once, now with an automatic shut-off"
            },
            {
              "domain": "Falls",
              "finding": "No falls"
            },
            {
              "domain": "Activities of daily living",
              "finding": "Independent in personal care; help with bills, medicines and appointments"
            },
            {
              "domain": "Hearing and vision",
              "finding": "Hearing aids since last week; reading glasses"
            }
          ],
          "ros": [
            {
              "system": "Constitutional",
              "status": "negative",
              "finding": "No fever, night sweats or unplanned weight loss"
            },
            {
              "system": "Eyes",
              "status": "negative",
              "finding": "No loss of vision"
            },
            {
              "system": "Ears, nose, mouth, and throat",
              "status": "positive",
              "finding": "Hearing loss, better with hearing aids"
            },
            {
              "system": "Cardiovascular",
              "status": "negative",
              "finding": "No chest pain, palpitations or fainting"
            },
            {
              "system": "Respiratory",
              "status": "negative",
              "finding": "No cough or shortness of breath"
            },
            {
              "system": "Gastrointestinal",
              "status": "negative",
              "finding": "No nausea or diarrhea on donepezil 5 mg"
            },
            {
              "system": "Genitourinary",
              "status": "negative",
              "finding": "Gets up once at night to pass urine"
            },
            {
              "system": "Musculoskeletal",
              "status": "negative",
              "finding": "Stiff hands in the morning, no swelling"
            },
            {
              "system": "Integumentary",
              "status": "negative",
              "finding": "No foot sores"
            },
            {
              "system": "Neurological",
              "status": "positive",
              "finding": "Memory loss; no weakness, tremor or falls"
            },
            {
              "system": "Psychiatric",
              "status": "negative",
              "finding": "Mood good; PHQ-2 0"
            }
          ],
          "exam": [
            {
              "system": "Constitutional",
              "finding": "Well and cheerful; weight 76.4 kg, BMI 23.6; blood pressure 126/76; pulse 68"
            },
            {
              "system": "Eyes",
              "finding": "Visual acuity 20/30 each eye with reading glasses; old scarring of both brows"
            },
            {
              "system": "Ears",
              "finding": "Hearing aids in place; canals clear"
            },
            {
              "system": "Cardiovascular",
              "finding": "Regular rhythm; no murmur; foot pulses normal"
            },
            {
              "system": "Respiratory",
              "finding": "Clear to auscultation"
            },
            {
              "system": "Abdomen",
              "finding": "Soft and non-tender"
            },
            {
              "system": "Feet",
              "finding": "Comprehensive diabetic foot examination: skin intact, no deformity; 10-g monofilament, pinprick and vibration sensation normal"
            },
            {
              "system": "Neurological",
              "finding": "No tremor, rigidity or slowness of movement; steady gait"
            }
          ],
          "assessment_plan": [
            {
              "display": "Periodic adult preventive visit completed",
              "assessment": "Health risk assessment reviewed and the prevention plan updated. HIV, hepatitis C and hepatitis B screening offered and done today. Lipids on atorvastatin 20 mg: LDL 79 mg/dL, at goal for diabetes without other risk; continue. After shared decision-making about PSA testing, with his dementia and his wishes in view, he chose not to be tested",
              "plan": [
                "Influenza, PCV20 and the first recombinant zoster dose today; Tdap at the next visit",
                "Results of the HIV and hepatitis tests by phone to him and his care partner",
                "Dilated eye examination booked with transport",
                "Next preventive visit in one year"
              ]
            },
            {
              "problem_id": "PRB-004",
              "display": "Type 2 diabetes",
              "assessment": "Foot examination normal. Off glipizide with no low readings; hemoglobin A1c due at the next visit",
              "plan": [
                "Hemoglobin A1c at the eleven-week visit",
                "Eye examination as booked"
              ]
            }
          ],
          "prevention_plan": [
            {
              "service": "Blood pressure",
              "status": "completed_today",
              "detail": "126/76 mmHg on lisinopril",
              "guideline_ids": [
                "GL-USPSTF-AB"
              ]
            },
            {
              "service": "Colorectal cancer screening",
              "status": "up_to_date",
              "detail": "Colonoscopy six years ago, normal; next due in four years",
              "guideline_ids": [
                "GL-USPSTF-CRC-2021"
              ]
            },
            {
              "service": "Prostate cancer screening",
              "status": "declined",
              "detail": "Shared decision-making for men 55 to 69; he chose not to be tested",
              "guideline_ids": [
                "GL-USPSTF-PROSTATE-2018"
              ]
            },
            {
              "service": "Lung cancer screening",
              "status": "not_indicated",
              "detail": "Never smoked",
              "guideline_ids": [
                "GL-USPSTF-LUNG-2021"
              ]
            },
            {
              "service": "Abdominal aortic aneurysm screening",
              "status": "not_indicated",
              "detail": "Recommended for men 65 to 75 who have ever smoked",
              "guideline_ids": [
                "GL-USPSTF-AAA-2019"
              ]
            },
            {
              "service": "Lipid screening and statin",
              "status": "completed_today",
              "detail": "Total cholesterol 154, HDL 49, LDL 79, triglycerides 128 mg/dL on atorvastatin 20 mg",
              "guideline_ids": [
                "GL-USPSTF-STATIN-2022",
                "GL-ADA-OLDER-2026"
              ]
            },
            {
              "service": "Diabetic foot examination",
              "status": "completed_today",
              "detail": "Normal, with monofilament",
              "guideline_ids": [
                "GL-ADA-OLDER-2026",
                "GL-CMID-2026"
              ]
            },
            {
              "service": "Diabetic eye examination",
              "status": "referred",
              "detail": "Requested at intake and not yet done; booked with transport now that he does not drive",
              "guideline_ids": [
                "GL-ADA-OLDER-2026",
                "GL-CMID-2026"
              ]
            },
            {
              "service": "HIV screening",
              "status": "completed_today",
              "detail": "Offered and accepted; one-time screening",
              "guideline_ids": [
                "GL-USPSTF-HIV-2019"
              ]
            },
            {
              "service": "Hepatitis C screening",
              "status": "completed_today",
              "detail": "Offered and accepted; one-time screening",
              "guideline_ids": [
                "GL-USPSTF-HCV-2020"
              ]
            },
            {
              "service": "Hepatitis B screening",
              "status": "completed_today",
              "detail": "Triple panel, recommended once for all adults",
              "guideline_ids": [
                "GL-CDC-HBV-2023"
              ]
            },
            {
              "service": "Depression screening",
              "status": "completed_today",
              "detail": "PHQ-2 0",
              "guideline_ids": [
                "GL-USPSTF-DEP-2023"
              ]
            },
            {
              "service": "Unhealthy alcohol use",
              "status": "completed_today",
              "detail": "A glass of wine on special occasions",
              "guideline_ids": [
                "GL-USPSTF-ALC-2018"
              ]
            },
            {
              "service": "Tobacco cessation",
              "status": "not_indicated",
              "detail": "Never smoked",
              "guideline_ids": [
                "GL-USPSTF-AB"
              ]
            },
            {
              "service": "Influenza vaccine",
              "status": "completed_today",
              "detail": "For the coming season",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "service": "Pneumococcal vaccine",
              "status": "completed_today",
              "detail": "PCV20 today; recommended for all adults 50 and older",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "service": "Recombinant zoster vaccine",
              "status": "completed_today",
              "detail": "First of two doses; second in two to six months",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "service": "Tetanus, diphtheria, and pertussis",
              "status": "due",
              "detail": "No booster he can recall; he chose Tdap at the next visit rather than a fourth injection today",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "service": "RSV vaccine",
              "status": "not_indicated",
              "detail": "For adults 50 to 74 only with certain conditions; his diabetes has no complications and needs neither insulin nor an SGLT2 inhibitor; due at 75",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            },
            {
              "service": "COVID-19 vaccine",
              "status": "declined",
              "detail": "Offered for the coming season; he will decide with his care partner",
              "guideline_ids": [
                "GL-CDC-IMZ-2026"
              ]
            }
          ],
          "advance_care_planning": "Voluntary advance care planning discussion of about 30 minutes with him and his care partner, at his request, while he can take part fully. His capacity for these decisions was assessed: he understood what a health care agent does, could explain why he chose his agent, and gave consistent answers. He named his care partner as his health care agent on a durable power of attorney for health care; the agent is recorded in the chart and is not named here. He said that what matters most is staying at home, being with the people close to him, and keeping his dignity; that he wants to keep going to the gym while he can; and that if he no longer knows the people close to him, he wants care focused on comfort at home, with no feeding tube and no machines to keep him alive. A financial power of attorney was discussed and he will arrange it. The plan will be revisited every six months and at any change in his condition.",
          "follow_up": "Eleven-week review in two weeks, with hemoglobin A1c and Tdap. Screening results by phone. Eye examination as booked. Second zoster dose in two to six months. Next preventive visit in one year",
          "guideline_ids": [
            "GL-PREV-2026",
            "GL-USPSTF-AB",
            "GL-CDC-IMZ-2026",
            "GL-ADA-OLDER-2026",
            "GL-ALZ-2024"
          ]
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic periodic preventive visit.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "ENC-007",
        "display": "Same-day sick visit for nausea and dizziness on donepezil",
        "status": "finished",
        "date": "2026-10-01",
        "visit_type": "sick",
        "type_coding": {
          "system": "http://snomed.info/sct",
          "code": "185345009",
          "display": "Encounter for symptom",
          "validation_status": "validated",
          "validated_on": "2026-11-05"
        },
        "documentation": {
          "chief_complaint": "Nausea, loose stools and dizziness for five days",
          "billing_note": "Problem-oriented office visit, established patient",
          "hpi": {
            "narrative": "Sugar Ray Robinson came in without an appointment with his care partner because of nausea, poor appetite and three or four loose stools a day for five days, with one episode of vomiting yesterday and dizziness when he stands up. Donepezil was raised from 5 mg to 10 mg at bedtime nine days ago; the symptoms began four days later. He has had vivid dreams since the increase. He has kept drinking water but has eaten little, and has kept taking metformin and lisinopril. No fever, blood in the stool, abdominal pain, chest pain or fainting. His home glucose readings have been 100 to 140 mg/dL. Nobody else at home is ill.",
            "elements": [
              {
                "label": "Onset",
                "value": "Five days ago, four days after donepezil was raised to 10 mg"
              },
              {
                "label": "Character",
                "value": "Nausea, loose stools, one vomit; dizziness on standing"
              },
              {
                "label": "Severity",
                "value": "Moderate; eating little"
              },
              {
                "label": "Associated signs and symptoms",
                "value": "Vivid dreams; no fever, blood, abdominal pain, chest pain or fainting"
              },
              {
                "label": "Context",
                "value": "Metformin and lisinopril continued; home glucose 100 to 140 mg/dL"
              }
            ]
          },
          "ros": [
            {
              "system": "Constitutional",
              "status": "positive",
              "finding": "Tired; poor appetite; no fever"
            },
            {
              "system": "Gastrointestinal",
              "status": "positive",
              "finding": "Nausea, one vomit, three or four loose stools a day; no blood or abdominal pain"
            },
            {
              "system": "Cardiovascular",
              "status": "positive",
              "finding": "Dizzy on standing; no chest pain, palpitations or fainting"
            },
            {
              "system": "Neurological",
              "status": "positive",
              "finding": "Vivid dreams; no new confusion beyond his usual memory loss, no weakness"
            },
            {
              "system": "Genitourinary",
              "status": "negative",
              "finding": "Passing urine, less than usual"
            }
          ],
          "exam": [
            {
              "system": "General",
              "finding": "Tired but alert, at his usual level of orientation; temperature 36.8 °C; pulse 56 and regular; blood pressure 118/70 seated and 106/66 standing, with dizziness"
            },
            {
              "system": "Mouth",
              "finding": "Dry mucous membranes"
            },
            {
              "system": "Abdomen",
              "finding": "Soft, non-tender, bowel sounds active"
            },
            {
              "system": "Cardiovascular",
              "finding": "Regular slow rhythm; no murmur"
            }
          ],
          "assessment_plan": [
            {
              "problem_id": "PRB-007",
              "display": "Donepezil side effects with mild dehydration",
              "assessment": "Cholinergic side effects of the higher donepezil dose: nausea, loose stools, vivid dreams and a slow pulse, with a standing drop in blood pressure and mild dehydration (creatinine 1.2 mg/dL, from 1.0). Sodium, potassium and glucose are safe. ECG shows sinus bradycardia without heart block. No sign of infection",
              "plan": [
                "Donepezil back to 5 mg, taken in the morning with breakfast",
                "Hold metformin and lisinopril for 48 hours, then restart once he is eating and drinking (sick-day rules)",
                "Small frequent drinks with salt and sugar; bland food",
                "Check glucose twice daily while metformin is held",
                "Return or call at once for fainting, a pulse below 50, vomiting that will not stop, or confusion worse than usual"
              ]
            },
            {
              "problem_id": "PRB-002",
              "display": "Alzheimer's disease with early onset",
              "assessment": "Donepezil 5 mg was tolerated for five weeks; a later trial of 10 mg in the morning, or a switch to a rivastigmine patch, can be discussed at the next visit",
              "plan": [
                "Continue donepezil 5 mg each morning"
              ]
            }
          ],
          "follow_up": "Nurse phone call tomorrow and in two days. Sixteen-week review in four weeks with potassium and creatinine",
          "guideline_ids": [
            "GL-ALZ-2024",
            "GL-ADA-OLDER-2026",
            "GL-BEERS-2023"
          ]
        },
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic unscheduled sick visit; the illness is not a historical claim.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      }
    ],
    "vital_sign_sets": [
      {
        "id": "VSET-001",
        "date": "2026-07-07",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 180,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 77.0,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 23.8,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 132,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 80,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 72,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 14,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.7,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 98,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs at intake, average of two readings.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "VSET-002",
        "date": "2026-07-21",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 180,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 76.8,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 23.7,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 128,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 78,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 70,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 14,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.6,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 98,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs; no measurement from his lifetime is used.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "VSET-003",
        "date": "2026-08-18",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 180,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 76.6,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 23.6,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 126,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 78,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 70,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 14,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.6,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 98,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs; no measurement from his lifetime is used.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "VSET-004",
        "date": "2026-09-22",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 180,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 76.2,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 23.5,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 128,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 76,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 64,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 14,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.6,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 98,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs; no measurement from his lifetime is used.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "VSET-005",
        "date": "2026-10-27",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 180,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 75.8,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 23.4,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 126,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 76,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 66,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 14,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.5,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 98,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs; no measurement from his lifetime is used.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "VSET-006",
        "date": "2026-09-08",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 180,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 76.4,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 23.6,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 126,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 76,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 68,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 14,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.6,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 98,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs at the preventive visit.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "VSET-007",
        "date": "2026-10-01",
        "measurements": [
          {
            "code": "8302-2",
            "display": "Body height",
            "value": 180,
            "unit": "cm"
          },
          {
            "code": "29463-7",
            "display": "Body weight",
            "value": 74.6,
            "unit": "kg"
          },
          {
            "code": "39156-5",
            "display": "Body mass index (BMI) [Ratio]",
            "value": 23.0,
            "unit": "kg/m2"
          },
          {
            "code": "8480-6",
            "display": "Systolic blood pressure",
            "value": 118,
            "unit": "mm[Hg]"
          },
          {
            "code": "8462-4",
            "display": "Diastolic blood pressure",
            "value": 70,
            "unit": "mm[Hg]"
          },
          {
            "code": "8867-4",
            "display": "Heart rate",
            "value": 56,
            "unit": "/min"
          },
          {
            "code": "9279-1",
            "display": "Respiratory rate",
            "value": 16,
            "unit": "/min"
          },
          {
            "code": "8310-5",
            "display": "Body temperature",
            "value": 36.8,
            "unit": "Cel"
          },
          {
            "code": "59408-5",
            "display": "Oxygen saturation in Arterial blood by Pulse oximetry",
            "value": 98,
            "unit": "%"
          }
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic seated vital signs at the sick visit; standing pressure in the note.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      }
    ],
    "social_history": [
      {
        "id": "SOC-001",
        "display": "Retired world champion boxer; lives in Los Angeles in the upper floor of a duplex with his care partner, who comes to visits with him; still visits the gym of the youth foundation he started",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic modern household anchored to his documented home in Los Angeles and the foundation; the care partner is synthetic, unnamed, and not modeled on any relative.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "SOC-002",
        "display": "Finished school to about the tenth grade; spent his working life in boxing and in business around it",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic education level, recorded because it affects the cognitive test scores.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "SOC-003",
        "display": "Drives a car; got lost twice in familiar streets this year; no crashes",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic driving history for the safety assessment.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "SOC-004",
        "display": "A handgun in the home, kept unloaded in a locked box",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic detail recorded for firearm safety.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "SOC-005",
        "display": "Does not smoke; a glass of wine on special occasions; no other drugs",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic substance history.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "SOC-006",
        "display": "Exercises daily: long walks and skipping rope; eats two large meals a day",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic activity and diet.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "SOC-007",
        "display": "Strengths and supports: discipline and daily exercise, pride in his career, a warm and sociable manner, his care partner, friends from boxing, and the young people at the foundation",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0003",
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic strengths anchored to his documented career and foundation.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      }
    ],
    "functional_status": [
      {
        "id": "FUNC-001",
        "display": "Independent in bathing, dressing, eating and walking; needs help with bills, medicines and appointments (Functional Activities Questionnaire 11, narrative); Timed Up and Go 9 seconds",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008",
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic functional status at intake.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      }
    ],
    "mental_status": [
      {
        "id": "MSE-001",
        "display": "Alert, cheerful and courteous; repeats a question twice in ten minutes; looks to his care partner for dates; speech fluent; mood good; no hallucinations or delusions; insight partial: he notices forgetting but feels it is normal for his age",
        "status": "current",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic mental-status finding; not a claim about his real mental state.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      }
    ],
    "consultation": {
      "referral": {
        "question": "Two years of progressive memory loss with getting lost while driving in a retired professional boxer of 63 with type 2 diabetes and hypertension; MoCA 18. Please stage the impairment, weigh Alzheimer's disease against traumatic encephalopathy syndrome and vascular disease, advise on biomarker testing and on eligibility for anti-amyloid therapy, and help us plan safety and support",
        "urgency": "Routine; at the memory clinic two weeks from now, on the same day as his two-week primary care visit, with brain MRI and audiometry that morning",
        "pertinent_history": "Retired world champion boxer: about 200 professional bouts over 25 years after an amateur career. Memory loss for about two years, worse in the past six months: repeated questions, missed bills and appointments, and lost twice in familiar streets while driving. Independent in personal care; needs help with finances and medicines (Functional Activities Questionnaire 11). MoCA 18 with losses in delayed recall, orientation and executive tasks; PHQ-9 4. About ten years of schooling. Diabetes on metformin and glipizide (hemoglobin A1c 6.4%); hypertension on lisinopril; atorvastatin. Diphenhydramine 25 mg nightly stopped today. Blood count, metabolic panel (creatinine 1.0 mg/dL, eGFR 85), B12 352 pg/mL and TSH 1.9 normal; urine albumin-to-creatinine ratio 14 mg/g. STOP-Bang 2. No anticoagulant. He has agreed not to drive until the work-up is done; a handgun at home is unloaded and locked with the key held by his care partner, who comes to visits",
        "questions": [
          "What is the stage of his impairment, and is the pattern most consistent with Alzheimer's disease?",
          "How should we think about traumatic encephalopathy syndrome and chronic traumatic encephalopathy after his boxing career, and about vascular disease?",
          "Which biomarker test do you advise, and should APOE genotyping be done?",
          "Is he a candidate for lecanemab or donanemab under the appropriate use recommendations?",
          "What do you advise for symptomatic treatment, driving, firearm safety, hearing and support for his care partner?"
        ]
      },
      "consultant_note": {
        "history": "Sugar Ray Robinson, a retired professional boxer of 63, is seen at the memory clinic with his care partner at the request of Dr. Pryce-Okonjo. He says his memory is not what it was but that this is normal at his age; his care partner describes two years of slowly worsening forgetfulness for recent events, repeated questions and stories, missed bills, and two episodes of getting lost while driving in familiar streets. There has been no sudden change, no hallucinations, no acting out of dreams, no falls and no change in personality, temper or mood. He boxed for about 25 years; he remembers many hard fights but cannot say how often he was dazed. He exercises daily and still goes to the gym of the youth foundation he started",
        "data_reviewed": "Dr. Pryce-Okonjo's intake note. MoCA 18 at intake (education point included); PHQ-9 4; Functional Activities Questionnaire 11. Blood count, metabolic panel, B12, TSH and urine albumin-to-creatinine ratio normal; hemoglobin A1c 6.4%. Brain MRI this morning: moderate bilateral hippocampal atrophy, left more than right, mild generalized atrophy, Fazekas 1 white matter change, six microbleeds at the gray-white junction of both frontal lobes and the right temporal lobe, no cortical superficial siderosis or infarct, and a cavum septi pellucidi. Audiometry this morning: mild to moderate bilateral high-frequency sensorineural hearing loss. No anticoagulant or antiplatelet drug. Today: MMSE 22; global CDR 1, sum of boxes 5.5",
        "exam": [
          {
            "system": "Neurological",
            "finding": "Cranial nerves normal; no rigidity, tremor, bradykinesia or dysarthria; normal strength, reflexes and coordination; steady narrow-based gait"
          },
          {
            "system": "Mental status",
            "finding": "Alert and courteous; repeats questions; impaired delayed recall that cueing helps little; mild executive slowing; language and visuospatial copying preserved; no psychotic symptoms"
          }
        ],
        "assessment": [
          {
            "problem_id": "PRB-001",
            "display": "Stage and pattern",
            "assessment": "Mild dementia (global CDR 1, MMSE 22, MoCA 18) with an amnestic presentation and progressive course, independent in personal care but dependent for complex tasks. With bilateral hippocampal atrophy, this is most consistent with Alzheimer's disease beginning before 65. Depression, thyroid disease, B12 deficiency and anticholinergic drugs have been excluded or addressed; sleep apnea risk is low; hearing loss is a treatable contributor"
          },
          {
            "problem_id": "PRB-001",
            "display": "Traumatic encephalopathy syndrome and vascular disease",
            "assessment": "Twenty-five years of professional boxing is substantial exposure to repetitive head impacts. Under the 2021 NINDS consensus criteria, traumatic encephalopathy syndrome is a research diagnosis for people with that exposure and progressive cognitive or neurobehavioral impairment; it is not meant to guide routine clinical care, and the underlying disease, chronic traumatic encephalopathy, can be confirmed only after death. He has no neurobehavioral dysregulation or parkinsonism, and the amnestic pattern with hippocampal atrophy points to Alzheimer's disease; repetitive head impacts may still add to his difficulty, as the microbleeds and cavum septi pellucidi suggest past injury. Vascular change is slight and does not explain his dementia"
          },
          {
            "display": "Biomarkers and APOE",
            "assessment": "Confirming Alzheimer's pathology will settle the diagnosis, which he wants, inform counseling and planning, and distinguish it from a mainly traumatic process. Amyloid PET is the test I advise. APOE genotyping informs the risk of amyloid-related imaging abnormalities for anti-amyloid therapy; since he is not a candidate, it would not change his care, and it carries implications for relatives. It can be offered with genetic counseling if he wishes"
          },
          {
            "display": "Anti-amyloid therapy",
            "assessment": "By stage and MMSE (20 to 30 for donanemab, 22 to 30 for lecanemab) he would otherwise fit, and he takes no anticoagulant. But both the lecanemab and donanemab appropriate use recommendations exclude people with more than four cerebral microbleeds on the pre-treatment MRI because of the risk of bleeding and amyloid-related imaging abnormalities. With six microbleeds he does not qualify, whatever his amyloid status"
          },
          {
            "problem_id": "PRB-004",
            "display": "Diabetes and blood pressure",
            "assessment": "Hemoglobin A1c 6.4% on glipizide is tighter than needed: for an older adult with cognitive impairment the ADA Standards advise a goal under 8.0% and avoiding drugs that cause hypoglycemia, which harms memory and raises the risk of falls. Blood pressure is well controlled"
          },
          {
            "display": "Treatment, safety and support",
            "assessment": "If amyloid is confirmed, a cholinesterase inhibitor offers modest benefit: donepezil 5 mg, then 10 mg after four to six weeks if tolerated, after a baseline ECG, watching for nausea, loose stools, vivid dreams and a slow pulse. Memantine is for moderate dementia. With CDR 1 and getting lost while driving, his driving risk is high and he should not drive. A firearm should not be kept in the home of a person with dementia. Hearing aids, exercise, social activity and support for his care partner, including respite, matter as much as medicine"
          }
        ],
        "recommendations": [
          "Amyloid PET to confirm Alzheimer's disease pathology; disclosure of the result with his care partner present if he wishes",
          "Not a candidate for lecanemab or donanemab: more than four microbleeds on MRI; APOE genotyping not needed for treatment and offered only with genetic counseling",
          "Traumatic encephalopathy syndrome recorded as a consideration only; it is a research diagnosis and does not change treatment",
          "If amyloid is positive: donepezil 5 mg after a baseline ECG, raised to 10 mg after four to six weeks if tolerated; step back to 5 mg, or take it in the morning, for nausea, diarrhea, vivid dreams or a slow pulse",
          "Stop glipizide and keep metformin, with a hemoglobin A1c goal under 8.0%",
          "No driving; remove the firearm from the home",
          "Hearing aids for both ears",
          "Care partner education and respite, with the Alzheimer's Association 24/7 Helpline and an adult day program; the GUIDE dementia care model once he has Medicare",
          "Advance care planning soon, while he can take part fully",
          "MoCA and CDR yearly, or sooner with change; repeat MRI only for an acute change"
        ],
        "communication": "Discussed with Dr. Pryce-Okonjo, who saw him the same day. The findings were explained to him and his care partner; he agreed to the amyloid PET, declined APOE testing, and agreed not to drive until the results visit",
        "follow_up": "Dr. Pryce-Okonjo will review the PET result with him at the six-week visit and continue his care; the memory clinic will see him again in a year, or sooner if he declines faster than expected or behavioral symptoms appear"
      },
      "guideline_ids": [
        "GL-ALZ-2024",
        "GL-TES-2021",
        "GL-AUR-LEC-2023",
        "GL-AUR-DON-2025",
        "GL-ADA-OLDER-2026",
        "GL-AAN-DRIVING-2010",
        "GL-GUIDE"
      ]
    }
  },
  "care_plan": {
    "health_concerns": [
      {
        "id": "HC-001",
        "display": "He wants to know why he is forgetting and what can be done",
        "status": "active",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008",
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic patient-centered concern.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "HC-002",
        "display": "He wants to keep his independence and keep working with the young fighters at the foundation",
        "status": "active",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0005"
          ],
          "synthetic_reason": "Synthetic patient-centered concern.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "HC-003",
        "display": "His care partner is worried about his driving and about managing alone",
        "status": "active",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic concern of the synthetic care partner.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      }
    ],
    "goals": [
      {
        "id": "GOAL-001",
        "display": "Find the cause of the memory loss and explain it to him in a way he can take in",
        "status": "completed",
        "target_date": "2026-08-18",
        "outcome": "Alzheimer's disease confirmed by amyloid PET; disclosed with his care partner present, at his request, with written notes",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic diagnostic goal.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "GOAL-002",
        "display": "No hypoglycemia, with hemoglobin A1c under 8.0%",
        "status": "completed",
        "target_date": "2026-10-27",
        "outcome": "Glipizide stopped after one reading of 68 mg/dL; no low readings since; A1c 6.4 to 6.9%",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic diabetes goal under the ADA Standards for older adults.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "GOAL-003",
        "display": "Stay safe: no driving and no firearm in the home",
        "status": "completed",
        "target_date": "2026-08-18",
        "outcome": "He stopped driving and the handgun was removed from the home",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic safety goal agreed with him.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "GOAL-004",
        "display": "Keep his days full and give his care partner regular breaks",
        "status": "completed",
        "target_date": "2026-10-27",
        "outcome": "Adult day program two days a week; walks and the foundation gym on other days; Alzheimer's Association helpline",
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic support goal.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      }
    ],
    "interventions": [
      {
        "id": "INT-001",
        "display": "Dementia work-up under the Alzheimer's Association guideline: history from him and his care partner, MoCA, function, depression screening, first-tier blood tests (blood count, metabolic panel, B12, TSH), a review of medicines for anticholinergic and sedating drugs, a sleep apnea screen, and brain MRI",
        "status": "completed",
        "guideline_ids": [
          "GL-ALZ-2024",
          "GL-ALZ-PC-2024",
          "GL-CMID-2026"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008",
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic diagnostic plan.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "INT-002",
        "display": "Cognitive neurology consultation at the memory clinic to stage the dementia, weigh Alzheimer's disease against traumatic encephalopathy syndrome and vascular disease, choose biomarker testing, and decide anti-amyloid eligibility",
        "status": "completed",
        "guideline_ids": [
          "GL-ALZ-2024",
          "GL-TES-2021",
          "GL-AUR-LEC-2023",
          "GL-AUR-DON-2025"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008",
            "CLM-0009",
            "CLM-0004"
          ],
          "synthetic_reason": "Synthetic specialist consultation.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "INT-003",
        "display": "Stop diphenhydramine, a strongly anticholinergic sleep aid; sleep habits and morning light instead",
        "status": "completed",
        "guideline_ids": [
          "GL-BEERS-2023"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic deprescribing at intake.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "INT-004",
        "display": "Driving: no driving until the evaluation is complete, with his care partner driving; firearm: unloaded and locked, with the key held by his care partner, until a decision with him",
        "status": "completed",
        "guideline_ids": [
          "GL-AAN-DRIVING-2010",
          "GL-ALZ-2024"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic safety plan at intake.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "INT-005",
        "display": "Amyloid PET to confirm Alzheimer's disease pathology; APOE genotyping not needed because he is not a candidate for anti-amyloid therapy, and offered only with counseling",
        "status": "completed",
        "guideline_ids": [
          "GL-ALZ-2024",
          "GL-AUR-LEC-2023",
          "GL-AUR-DON-2025"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008",
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic biomarker plan decided at the consultation.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        },
        "recorded_date": "2026-07-21"
      },
      {
        "id": "INT-006",
        "display": "Donepezil 5 mg at bedtime with a baseline ECG and pulse checks, raised to 10 mg after four to six weeks if tolerated; taken in the morning if dreams are vivid",
        "status": "completed",
        "guideline_ids": [
          "GL-ALZ-2024",
          "GL-CMID-2026"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008",
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic cholinesterase inhibitor plan decided at the diagnosis visit.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        },
        "recorded_date": "2026-08-18"
      },
      {
        "id": "INT-007",
        "display": "Diabetes deintensified under the ADA Standards for older adults: stop glipizide, continue metformin, hemoglobin A1c goal under 8.0%, sick-day rules (hold metformin when not eating or drinking), and B12 checked periodically",
        "status": "completed",
        "guideline_ids": [
          "GL-ADA-OLDER-2026",
          "GL-CMID-2026"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0008"
          ],
          "synthetic_reason": "Synthetic diabetes plan decided at the diagnosis visit.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        },
        "recorded_date": "2026-08-18"
      },
      {
        "id": "INT-008",
        "display": "Blood pressure under 130/80 mmHg on lisinopril, with potassium and creatinine checks",
        "status": "completed",
        "guideline_ids": [
          "GL-ADA-OLDER-2026",
          "GL-CMID-2026"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [
            "CLM-0009"
          ],
          "synthetic_reason": "Synthetic blood pressure plan.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "INT-009",
        "display": "Hearing aids for both ears, fitted by the audiologist",
        "status": "completed",
        "guideline_ids": [
          "GL-ALZ-2024"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic hearing plan decided at the diagnosis visit after audiometry.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        },
        "recorded_date": "2026-08-18"
      },
      {
        "id": "INT-010",
        "display": "Stop driving after the diagnosis (CDR 1 and getting lost), with transport planned; the handgun removed from the home",
        "status": "completed",
        "guideline_ids": [
          "GL-AAN-DRIVING-2010",
          "GL-ALZ-2024"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic safety decisions made with him at the diagnosis visit.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        },
        "recorded_date": "2026-08-18"
      },
      {
        "id": "INT-011",
        "display": "Caregiver support: education, the Alzheimer's Association 24/7 Helpline, an adult day program for respite, a caregiver burden check, and the Medicare GUIDE dementia care model once he has Medicare",
        "status": "completed",
        "guideline_ids": [
          "GL-GUIDE",
          "GL-ALZ-2024"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic support plan decided at the diagnosis visit.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        },
        "recorded_date": "2026-08-18"
      },
      {
        "id": "INT-012",
        "display": "Advance care planning while he can take part fully: a health care agent and his values, at the preventive visit",
        "status": "completed",
        "guideline_ids": [
          "GL-ALZ-2024"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic plan to plan ahead early.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      },
      {
        "id": "INT-013",
        "display": "Exercise, social activity and diabetes and blood pressure control as the brain-health measures with the most support",
        "status": "completed",
        "guideline_ids": [
          "GL-ALZ-2024",
          "GL-ADA-OLDER-2026"
        ],
        "provenance": {
          "evidence_grade": "S",
          "claim_ids": [],
          "synthetic_reason": "Synthetic lifestyle plan.",
          "author": "The Human Record generator",
          "created": "2026-11-05T12:00:00-05:00"
        }
      }
    ],
    "guidelines": [
      {
        "guideline_id": "GL-ALZ-2024",
        "title": "Alzheimer's Association clinical practice guideline for the Diagnostic Evaluation, Testing, Counseling, and Disclosure of Suspected Alzheimer's Disease and Related Disorders (DETeCD-ADRD): Executive summary of recommendations for specialty care",
        "publisher": "Alzheimer's Association (Alzheimers Dement 2025;21(1):e14337)",
        "url": "https://pubmed.ncbi.nlm.nih.gov/39713957/",
        "version_or_year": "2024"
      },
      {
        "guideline_id": "GL-ALZ-PC-2024",
        "title": "Alzheimer's Association clinical practice guideline for the Diagnostic Evaluation, Testing, Counseling, and Disclosure of Suspected Alzheimer's Disease and Related Disorders (DETeCD-ADRD): Executive summary of recommendations for primary care",
        "publisher": "Alzheimer's Association (Alzheimers Dement 2025)",
        "url": "https://pubmed.ncbi.nlm.nih.gov/39713942/",
        "version_or_year": "2024"
      },
      {
        "guideline_id": "GL-CMID-2026",
        "title": "CMID: Clinical Monitoring Intelligence Database, Alzheimer's disease, diabetes type 2 and hypertension monographs",
        "publisher": "Aether Forge",
        "url": "https://patrickrutledge.github.io/topthirty/",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-AUR-LEC-2023",
        "title": "Lecanemab: Appropriate Use Recommendations",
        "publisher": "J Prev Alzheimers Dis 2023;10(3):362-377 (Cummings J et al.)",
        "url": "https://pubmed.ncbi.nlm.nih.gov/37357276/",
        "version_or_year": "2023"
      },
      {
        "guideline_id": "GL-AUR-DON-2025",
        "title": "Donanemab: Appropriate use recommendations",
        "publisher": "J Prev Alzheimers Dis 2025;12(5):100150 (Rabinovici GD et al.)",
        "url": "https://pubmed.ncbi.nlm.nih.gov/40155270/",
        "version_or_year": "2025"
      },
      {
        "guideline_id": "GL-TES-2021",
        "title": "National Institute of Neurological Disorders and Stroke Consensus Diagnostic Criteria for Traumatic Encephalopathy Syndrome",
        "publisher": "Neurology 2021;96(18):848-863",
        "url": "https://pubmed.ncbi.nlm.nih.gov/33722990/",
        "version_or_year": "2021"
      },
      {
        "guideline_id": "GL-ADA-OLDER-2026",
        "title": "13. Older Adults: Standards of Care in Diabetes-2026",
        "publisher": "American Diabetes Association (Diabetes Care 2026;49(Suppl 1):S277-S296)",
        "url": "https://pubmed.ncbi.nlm.nih.gov/41358888/",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-BEERS-2023",
        "title": "American Geriatrics Society 2023 updated AGS Beers Criteria for potentially inappropriate medication use in older adults",
        "publisher": "American Geriatrics Society (Journal of the American Geriatrics Society)",
        "url": "https://pubmed.ncbi.nlm.nih.gov/37139824/",
        "version_or_year": "2023"
      },
      {
        "guideline_id": "GL-AAN-DRIVING-2010",
        "title": "Practice Parameter update: Evaluation and management of driving risk in dementia",
        "publisher": "American Academy of Neurology (Neurology 2010;74(16):1316-1324)",
        "url": "https://pubmed.ncbi.nlm.nih.gov/20385882/",
        "version_or_year": "2010"
      },
      {
        "guideline_id": "GL-GUIDE",
        "title": "Guiding an Improved Dementia Experience (GUIDE) Model",
        "publisher": "Centers for Medicare & Medicaid Services, Innovation Center",
        "url": "https://www.cms.gov/priorities/innovation/innovation-models/guide",
        "version_or_year": "2024"
      },
      {
        "guideline_id": "GL-PREV-2026",
        "title": "Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements",
        "publisher": "Aether Forge",
        "url": "https://patrickrutledge.github.io/preventative_services/",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-USPSTF-AB",
        "title": "USPSTF A and B Recommendations",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation-topics/uspstf-a-and-b-recommendations",
        "version_or_year": "2026"
      },
      {
        "guideline_id": "GL-USPSTF-CRC-2021",
        "title": "Colorectal Cancer: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/colorectal-cancer-screening",
        "version_or_year": "2021"
      },
      {
        "guideline_id": "GL-USPSTF-PROSTATE-2018",
        "title": "Prostate Cancer: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/prostate-cancer-screening",
        "version_or_year": "2018"
      },
      {
        "guideline_id": "GL-USPSTF-LUNG-2021",
        "title": "Lung Cancer: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/lung-cancer-screening",
        "version_or_year": "2021"
      },
      {
        "guideline_id": "GL-USPSTF-AAA-2019",
        "title": "Abdominal Aortic Aneurysm: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/abdominal-aortic-aneurysm-screening",
        "version_or_year": "2019"
      },
      {
        "guideline_id": "GL-USPSTF-STATIN-2022",
        "title": "Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medication",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/statin-use-in-adults-preventive-medication",
        "version_or_year": "2022"
      },
      {
        "guideline_id": "GL-USPSTF-HIV-2019",
        "title": "Human Immunodeficiency Virus (HIV) Infection: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/human-immunodeficiency-virus-hiv-infection-screening",
        "version_or_year": "2019"
      },
      {
        "guideline_id": "GL-USPSTF-HCV-2020",
        "title": "Hepatitis C Virus Infection in Adolescents and Adults: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/hepatitis-c-screening",
        "version_or_year": "2020"
      },
      {
        "guideline_id": "GL-CDC-HBV-2023",
        "title": "Screening and Testing for Hepatitis B Virus Infection: CDC Recommendations — United States, 2023",
        "publisher": "Centers for Disease Control and Prevention (MMWR Recommendations and Reports)",
        "url": "https://pubmed.ncbi.nlm.nih.gov/36893044/",
        "version_or_year": "2023"
      },
      {
        "guideline_id": "GL-USPSTF-DEP-2023",
        "title": "Depression and Suicide Risk in Adults: Screening",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/screening-depression-suicide-risk-adults",
        "version_or_year": "2023"
      },
      {
        "guideline_id": "GL-USPSTF-ALC-2018",
        "title": "Unhealthy Alcohol Use in Adolescents and Adults: Screening and Behavioral Counseling Interventions",
        "publisher": "U.S. Preventive Services Task Force",
        "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/unhealthy-alcohol-use-in-adolescents-and-adults-screening-and-behavioral-counseling-interventions",
        "version_or_year": "2018"
      },
      {
        "guideline_id": "GL-CDC-IMZ-2026",
        "title": "Adult Immunization Schedule by Age",
        "publisher": "Centers for Disease Control and Prevention",
        "url": "https://www.cdc.gov/vaccines/hcp/imz-schedules/adult-age.html",
        "version_or_year": "2026"
      }
    ]
  },
  "review": {
    "schema_validation": {
      "status": "not_started",
      "notes": "Run scripts/build.ps1 -Conformance."
    },
    "clinical_review": {
      "status": "not_started",
      "notes": "Awaiting clinician review; check the exclusion from lecanemab and donanemab on six microbleeds, amyloid PET in a man who is not a treatment candidate, APOE genotyping not done, the handling of traumatic encephalopathy syndrome as a research diagnosis, donepezil 10 mg reduced to 5 mg after gastrointestinal side effects, stopping glipizide at hemoglobin A1c 6.4%, and the driving and firearm decisions."
    },
    "provenance_review": {
      "status": "not_started",
      "notes": "Sources: UPI obituary (1989), UPI report of a Sports Illustrated article (1987), the Michigan Sports Hall of Fame, the West Adams Heritage Association and Boxing News. The International Boxing Hall of Fame site refused connection; the New York Times and Los Angeles Times obituaries could not be fetched; Wil Haygood's Sweet Thunder was not read. The birthplace is disputed (Ailey, Georgia, or Detroit), and record counts differ by source. No source dates his Alzheimer's diagnosis."
    },
    "safe_messaging_review": {
      "status": "not_started",
      "notes": "Dementia claims use only the documented press reports (Alzheimer's disease, diabetes, hypertension in 1987; Alzheimer's disease and diabetes at his death) and are marked sensitive. Dementia pugilistica and chronic traumatic encephalopathy are recorded only as an R roster claim. No relative is named in the modern episode; the care partner is synthetic, unnamed and not modeled on any relative, and family disputes in the 1987 report are not used."
    }
  }
}
